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A vast body of literature shows that the electrospinning technique offers 
unique advantages in the production of tissue engineering scaffolds compared 
to other methods in terms of simplicity, high surface-to-volume ratio scaffolds 
and process versatility. Various reports have been published citing the 
suitability of electrospun fibrous meshes as tissue engineering scaffolds due 
to their unique physical properties. However, as promising as it may seem, 
this technology is still in its infancy and further development is critical before it 
can be used for any practical biomedical applications. Moving towards the 
next generation of electrospun tissue engineering scaffolds, increasing 
research efforts are being focused on issues such as bio-functionalization, 
three-dimensionality and improved biomechanical properties of the scaffolds. 
 The research project outlined in this thesis was aimed to address the 
first two issues mentioned. To do so, electrospinning system was setup and 
optimized for the fabrication of poly (-caprolactone)-based (PCL) fibrous 
meshes. First step of bio-functionalization of the PCL meshes was the 
incorporation of a ubiquitous natural extracellular matrix (ECM) protein 
component, collagen, creating a synthetic-natural electrospun composite fiber. 
The effects of collagen incorporation were investigated with respect to the 
resulting mesh’s ability to support in vitro osteogenic morphogenesis. 
Compared to PCL alone, its collagen composite (PCL/Col) was proven to be 
more osteo-conductive as judged by proliferative capacity of bone marrow 





Functionalization of the PCL with gelatin yielded a less optimum osteogenic 
response compared to collagen. 
 Addressing the second issue of three-dimensionality of electrospun 
scaffolds, a novel hybrid electrospun mesh was fabricated via a modified 
electrospinning system. The new system enabled simultaneous 
electrospinning of micron-sized PCL/Col fibers with electrospraying of 
hyaluronic-acid derived hydrogel, HeprasilTM and their combination into a 
single scaffold entity. The novel hybrid PCL/Col-Hep mesh allowed cellular 
infiltration throughout its architecture as assayed in vitro using a model 
osteoblast cell line. This method proved to be significantly better than other 
modifications method attempted here. A second step of bio-functionalization 
was introduced into this mesh by the incorporation of bioactive growth factors 
vascular endothelial growth factor (VEGF), platelet derived growth factor 
(PDGF-BB) and bone morphogenetic proteins (BMP-2) within the HeprasilTM 
component. Sustained time-release profiles were obtained through this 
method highlighting the potential of the mesh as a cytokine delivery vehicle. 
Furthermore, bio-activities of the proteins were retained in this manner 
indicating minimal processing damage.  
 Investigations into the performance of this novel hybrid mesh as a 
three-dimensional (3D), bio-functional tissue engineering scaffold were carried 
out in an in vitro neo-vascularization model. Co-culture of endothelial cells and 
fibroblast were utilized as a model system optimized in a 3D setting on the 
PCL/Col-Hep meshes. The fibrous mesh surface properties proved to be 
suitable for the culture of both cell types. The interplay of the co-cultured cells 





the surface and within the mesh’s interior implying a more physiological 
phenotype expression of the cells. Furthermore, similar results were attained 
when endothelial cells and fibroblast were cultured on PCL/Col-Hep meshes 
impregnated with angiogenic factors VEGF and PDGF-BB and without 
exogenous supplementation of the cytokines in the media. This signifies the 
potential therapeutic benefits in cytokine delivery in the scaffold. 
 In conclusion, the work presented in this thesis provided a method of 
fabricating the next generation of electrospun scaffolds capable of 3D tissue 
integration and bioactive factor delivery. Such a technological advancement 
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Electrospinning has swiftly gained interests in the tissue engineering field as a 
rapid and reliable method of scaffold fabrication. Due to the physical 
similarities between the fibers and natural extracellular matrix (ECM), it is 
being exploited in the production of ECM-mimetic scaffolds. At its current 
development, electrospinning is not without a drawback. Due to the very 
nature of their deposition, electrospun fibers prohibit the infiltration of cells into 
their architecture. Eventually, this fact will limit the potential use of electrospun 
scaffolds as tissue engineering scaffolds. 
 This thesis was driven by the need to overcome this limitation and to 
further develop the electrospinning system as a method of fabricating truly 
three-dimensional (3D) tissue engineering constructs. As a preliminary tissue 
model, the periosteum was chosen due to its importance in the repair and 
regeneration of bone. Furthermore, not much emphasis has been placed in 
engineering a functional periosteum substitute. Two independent attempts to 
engineer periosteum substitutes were done using collagen sponge grafts for 
skin and de-cellularized dermal matrices [1, 2]. These structures, however, 
may not be suitable for the reconstruction of the periosteum and possibility of 
immune response and pathogen transfer exists when de-cellularized matrices 
are involved. Multi-functionalities of the periosteum as a tissue capable of 
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initiating bone healing, vascularization network and a barrier membrane for 
soft tissue were not addressed by the models. Thus, explorations into novel 
materials and architectures are needed for functional periosteal grafts. 
 The hypothesis behind this thesis is that a novel synthetic-natural 
hybrid fibrous mesh fabricated via modified electrospinning system will 
support both bone morphogenesis and recapitulation of vascular networks to 
be potentially used as periosteal graft. An envisioned periosteal substitute 
produced by the electrospinning technique is shown in Figure 1 below. 
Mimicking the native periosteum structure, the scaffold would have a cell-
penetrable fibrous zone for the formation of fibrous tissue and vascular 
networks. Beneath this zone, a cambium layer is situated for the possible 
delivery of mesenchymal cells to aid underlying bone repair. As an added 
functionality, hydrogel-based vehicles may be incorporated into the structure 
to permit delivery and time-release of relevant growth factors (i.e. angiogenic 
and osteogenic). 
 
Figure 1. A model of a possible periosteal tissue substitute made of 
electrospun fibers. The envisioned scaffolds would have two main layers: 
fibrous layer to accommodate three-dimensional highly vascular, fibrous 
tissue and cambium layer to house mesenchymal cells capable of assisting 
bone repair.  
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Aims and objectives 
 
In order to provide a thorough assessment of the hypothesis and achievement 
of a functional periosteal graft, this research project was systematically 
divided into three specific aims: 
1. Establishment of the cambium layer mimicking surface. 
PCL/Col hybrid meshes were created using the electrospinning 
system. Physical and chemical properties of the mesh were then 
characterized. In order to investigate its potential as a cambium layer, 
the ability of PCL/Col mesh to support in vitro bone tissue formation 
was studied. Further study was also made comparing the efficacy of 
replacing collagen with denatured collagen, gelatin. 
2. Fabrication of cell-permeable electrospun matrices as the fibrous layer. 
 The fibrous layer of the periosteum is a 3D layer comprising of highly 
fibrous tissues and vascular network, hence mimicry of this layer would 
require 3D integration of cells and scaffold. Modifications of the 
electrospinning system were performed to explore methods which 
would allow cellular infiltration into the scaffold’s architecture. In vitro 
experiments were carried out to determine the most optimum method 
of achieving a truly 3D cell-scaffold construct via electrospinning. 
3. Assessment of the angiogenic capacity of the fibrous layer. 
 Vascularization determines the survival of the implanted scaffolds and 
ultimately the success of tissue repair. Functionality of the electrospun 
meshes were further enhanced via growth factors incorporations. The 
release profiles of VEGF, PDGF-BB and BMP-2 from the scaffolds 
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were studied. Also, recapitulation of endothelial capillary formation in 
the scaffolds was investigated through the usage of an endothelial-





Three sub-projects with specific sets of experiments were planned to achieve 
individual objectives stated above: 
1. Establishment of the cambium-layer mimicking surface. 
  Set up of electrospinning system and optimization of electrospinning 
of PCL fibrous meshes was performed to obtain good fiber 
morphology. 
  Following the establishment of electrospinning, a synthetic-natural 
composite of PCL and collagen (PCL/Col) fibrous matrices was 
fabricated and characterized for their morphology, collagen localization 
and mechanical properties. 
  As the cambium layer acts as a mesenchymal cells reservoir, the 
ability of PCL/Col meshes to support their in vitro attachment, 
proliferation and bone-like tissue morphogenesis was studied. 
  Investigations into the possibility of electrospinning-induced collagen 





2. Fabrication of cell-permeable electrospun matrices as the fibrous layer. 
  Several methods of achieving 3D structures via electrospinning and 
its modifications were explored. This included dual electrospinning of 
two polymeric fibers followed by selective leaching, fabrication of 
micro-fiber meshes and co-deposition of electrospun fibers and 
electrosprayed HeprasilTM hydrogel. 
  The different hybrid meshes were characterized for their 
morphology, fiber species localization and hydrogel distribution. 
  In vitro analysis with a model osteoblast cell line was performed for 
the final analysis of the cell-permeability of the different scaffolds. 
Quantitative analysis was performed to objectively compare the 
different methods used.  
 
3. Assessment of the angiogenic capacity of the fibrous layer. 
  As a model for an in vitro angiogenic response, a co-culture system 
of endothelial cells and fibroblast was selected and optimized. 
  The scaffold with the most optimum cellular infiltration capability, 
PCL/Col co-deposited with HeprasilTM (PCL/Col-Hep), was used as the 
model matrix for the fibrous layer. 
  Attachment of endothelial cells and fibroblast were studied on 
PCL/Col-Hep to determine biocompatibility of the fibers. 
  Optimizations were performed for 3D co-culture of EC and fibroblast 
to determine the optimal seeding method and parameters. Formations 
of endothelial capillary networks and extensive cellular infiltrations were 
primary criteria for successful parameters. 
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  The potential of the PCL/Col-Hep mesh to function as a growth 
factor delivery vehicle was investigated by loading of the HeprasilTM 
component of the scaffold to release VEGF, PDGF-BB and BMP-2 in 
vitro. Bioactivity of the loaded factors was also assayed to analyze the 
effects of electrospraying on the protein stability. 
  The ability of the growth factor loaded PCL/Col-Hep mesh to induce 
in vitro endothelial network formation was examined as a test of the 






















The loss or failure of tissues or organs due to injuries or diseases remain one 
of the most complicated and costly medical challenges. Conventional 
treatments usually involve surgical restoration, tissue or organ transplantation 
and replacement with bio-artificial devices. Transplantation, although seen as 
the gold standard for treatment, is not without its limitations. More often than 
not, demand for a replacement tissue or organ far exceeds supply. Moreover, 
transplantation carries a risk of disease and pathogen transmission from 
donor to patient. 
 To overcome this dilemma, the field of tissue engineering emerged with 
the ultimate goal to develop biological substitutes that restore, maintain or 
improve tissue function [3]. By combining life sciences, engineering principles 
and innovation, tissue engineering holds enormous potential in confronting the 
supply crisis by providing alternative sources of the tissues/organs in the 
laboratory. As previously outlined by Langer and Vacanti, three general 
strategies are employed in the engineering of tissues and organs [4]: 
1. Cell replacement therapy which involves substitution of 
damaged/loss cells with new ones that would provide functionality; 
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2. Bioactive molecules approach which involves production, 
purification and delivery of therapeutic molecules such as growth 
factors to repair and regenerate target tissues; 
3. Matrix approach which may or may not involve cells placed in 
matrices or structures fashioned from natural, synthetic or hybrid 
materials. These constructs would either permanently or temporarily 
take on the function of the damaged or lost tissue and at the same 
time aid in the regeneration of the native tissue. 
  
 This field however, is still growing and not without its own obstacles. 
One major issue is achieving the proper three-dimensional (3D) architecture 
of the intended tissue complete with its complexity and functionality. The 
matrix approach is often employed to create the scaffolding structure for 
tissue support as well as a cellular micro-environment [5]. Our current state of 
material design and fabrication process is able to produce intricate and 
complex structures as scaffolds. Although far from perfect, some promising 
yields have been seen when scaffolds are used in conjunction with cell 
therapy. With the rapid advancement of knowledge in cell and tissue biology, 
and new breakthroughs in material engineering, tissue engineering is 






Scaffold-based tissue engineering 
 
The concept of scaffold-based tissue engineering involves constructs made of 
viable cells supported with bioactive molecules and structural scaffolding 
material utilized in the repair/regeneration of damaged or diseased tissues [6, 
7]. The ideal intention is for the construct to support migration, proliferation 
and differentiation of cells and ultimately guide development and maturation of 
tissue into a mature and healthy state. This field, however, is still in its infancy. 
It is generally accepted that an ideal and universal scaffold for repair and 
regeneration of various tissues in the body does not exist. Instead, due to the 
diversity and complexity of individual tissues and organs, tailor-made scaffold 
design and engineering is required. These would include material selection, 
fabrication process, architecture and geometry determination, surface 
biochemical tailoring and so on [8]. 
 There are, however, several generally accepted minimum requirements 
for a tissue engineered scaffold in terms of biochemical and physical 
properties. As an initial tissue replacement, the scaffold should possess 
sufficient mechanical strength and stiffness to substitute the damaged tissues. 
This can be tailored by selecting appropriate material composition, build and 
architecture. The scaffold ought to be biocompatible and not invoke 
inflammatory reaction post implantation. Should a biodegradable material be 
used, the degradation product must not elicit a foreign body response which 
may lead to implant failure in vivo. To promote the development of functional 
new tissue, the scaffold ideally should impart regulatory effects towards 
appropriate cellular functions such as adhesion, migration, proliferation and 
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differentiation [9]. For larger scaffolds, issues of pore size, degree of porosity 
and pore inter-connectivity become critical [10]. These features are significant 
in ensuring the success of the implant by allowing host tissue invasion and 
vascularization. 
 Since the rapid growth of the tissue engineering field in the late 1990s, 
a growing list of materials has been investigated for the application as tissue 
engineering scaffolds. These materials are classified into three general 
groups: naturally-derived, synthetic and a hybrid of both. Naturally-derived 
materials have the advantage of being more biologically relevant and more 
susceptible towards re-modeling by the cells; on the other hand, synthetic 
polymers can be manufactured reproducibly on a larger scale with tunable 
properties. Collagen, fibrin, chitosan and hyaluronan are some examples of 
naturally-derived materials that have been investigated as potential tissue 
engineering scaffold candidates. From the synthetic material group, the 
polyester family of polymers e.g. polyglycolide (PGA), polylactide (PLA), 
poly(caprolactone) (PCL) is arguably the most studied due to their 
biodegradability, relatively biocompatible nature and good mechanical 
properties [11-14]. Non-biodegradable polymers such as polyhydroxybutyrate 
(PHB), polyurethane and polycarbonate have also been investigated as cell 
and tissue substrates [15-17]. Hybrid or composite materials are obtained by 
combining natural materials with synthetic polymers aimed to exploit the 
beneficial characteristics of each component.  
 With demands for virtually every tissue in the human body, a broad 
selection is available in terms of scaffold fabrication methods. Each method 
offers its own merits and suitability is dictated by the intended tissue’s 
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requirements. Injection molding, solvent casting & particulate leaching, gas 
foaming and thermally-induced phase separation (TIPS) are straight forward 
and widely reported methods for fabricating scaffolding structures[18]. 
Unfortunately, these methods lack precise control over porosity, pore size and 
architectural intricacy. The rapid prototyping (RP) method aims to overcome 
these issues by incorporating computer aided design and manufacturing 
(CAD/CAM) technology into the scaffold fabrication process [19]. As a result, 
complex 3D structures with defined pore size and geometry can be attained. 
Fused Deposition Modeling (FDM), Selective Laser Sintering (SLS) and Three 
Dimensional Printing (3DP) are some examples of techniques that fall into the 
RP category [20]. However, structures fabricated by these techniques hold 
some disadvantages in the application as tissue engineering scaffolds. As 
most involve harsh conditions during processing i.e. solvent, heat, intense 
light, etc., these techniques are usually limited to synthetic polymers [21]. 
Furthermore, feature sizes produced by these methods are typically too large 
to be relevant at the molecular and cellular level. 
 New generation bio-scaffolds aim to mimic the biophysical and 
biochemical make-up of the native extracellular matrix (ECM) [22]. These are 
the so-called bio-mimetic scaffolds. Ideally, this ECM analogue should imitate 
the micro- and nano-topographical features of the ECM. For example, 
collagen fibrils, which are major protein components of the ECM in virtually 
every tissue in the body, has a diameter in the range of 50 to 500 nm [23]. 
Nanofabrication techniques allow us to produce fibrous structures which are 
close to or within the range of collagen and other types of ECM molecules 
[24]. Three methods are often employed in fabricating these nano-fibrous 
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scaffolds: self-assembly, phase separation and electrospinning [25-27]. 
Although these technologies have their pros and cons, all three are capable of 
generating fibrillar structures down to the nanometer scale. 
 This thesis focuses on the development of a tissue engineering 
scaffold based on the electrospinning technique. Electrospinning was chosen 
due to its simple setup, cost effectiveness and versatility with different 
polymer systems. It is the objective of this thesis to further the development of 
the electrospinning technique, thus enabling a more functional and 3D 
scaffold build.  
  
 
Electrospinning and tissue engineering 
 
Development of the technique of fluid dispersion using electrostatic forces 
dates back to the very early 20th century [28, 29]. Methods of fabricating 
threads and fibers from artificial polymers using high voltage electrostatic 
energy were described by Anton Formhals in a series of patents starting from 
1934 [30-33]. The late 20th century saw an exponential growth of renewed 
interest in electrospinning as a fiber production process. Electrospun fibers 
were seen as attractive and promising materials to be used as filtering media, 
substrates for enzymes as catalysts, textile and tissue engineering scaffolds. 
 Conventional electrospinning involves a polymer solution (synthetic, 
natural or a combination) placed in a metal capillary. Typically, a high voltage 
is applied to this capillary or spinneret which is facing a collector of a different 
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potential. Upon reaching a critical threshold, a Taylor cone is formed at the 
spinneret tip. At this cone, polymer surface tension is counterbalanced by the 
localized charge due to strong applied electrostatic forces resulting in ejection 
of polymer material from the tip [34]. As the ejected polymer jet travels to the 
collector, statistical perturbations occur and result in deviation from the most 
direct path. As a charged entity moving in an electric field, a force that is right 
angle to the field is imparted on the polymer jet, causing the jet to assume a 
spiraling path [35]. The polymer surface tension will eventually restrict the 
diameter of the spiral. Diameter reduction up to five orders of magnitude is 
experienced by the polymer jet as it undergoes bending and stretching in the 
spiraling path. Electrospun fibers in the diameter range of 50 nm to 10 m are  
 
 
Figure 2. A basic electrospinning setup is comprised of polymer solution in a 
spinneret being electrically charged by a high voltage generator. At the 
threshold, the Taylor cone is formed where polymer material is ejected from 
the tip due to electrostatic forces overwhelming the surface tension. A 




commonly observed on the collector. A schematic setup of a basic 
electrospinning system is shown in Figure 2. 
 As the native ECM surrounding the cells is composed of nanometer-
scaled proteins and glycosaminoglycan (GAG) molecules, fibrous structures 
produced by electrospinning hold the potential of serving as temporary ECM 
until repair and regeneration occurs. Electrospinning is also more 
advantageous compared to other nanofiber producing techniques such as 
self-assembly and phase separation, by being more cost effective, able 
generate structures with aligned fibers and versatile with polymer selections 
[36]. These fibrous structures also possess high surface-to-volume ratio and 
degree of porosity therefore increasing the surface available for cell growth 
and mass transport of waste and nutrients. It has been established that 
cellular attachment and morphology are modulated by nano-scaled features 
on man-made substrates [37, 38]. Furthermore, the morphological similarity 
between nanofibrous structures and ECM itself is shown to improve cellular 
response and overall biocompatibility [39, 40].  
 Numerous studies have been reported on the possible exploitation of 
electrospun fibers as tissue engineering scaffolds. Collagen is widely reported 
as a very promising scaffolding material and pure collagenous nano-fibrous 
meshes by electrospinning have been described [41-43]. Furthermore, 
collagen nanofibers in its pure or composite form with other polymers, have 
been studied as possible scaffolding material for the engineering of skin, 
cartilage and vascular tissues [42, 44, 45]. A vast number of synthetic 
biodegradable polymers have been electrospun and studied as well. Various 
cell types showed excellent attachment, proliferation and phenotype when 
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cultured on these artificial nanofibers [46-49]. Among the more commonly 
used biodegradable synthetic polymers, poly (L-lactic acid) (PLLA) and PCL 
were found to be optimum when used in conjunction with chondrocytes and 
mesenchymal stem cells (MSC) [50]. Nanofibrous scaffolds and their 
composites have also been shown to support endothelial cells and smooth 
muscle cells for blood vessel engineering [51, 52]. Osteoprogenitor cells 
showed good attachment, proliferation and differentiation into the 
mesenchymal lineages, opening the possibility of using electrospun fibers as 
scaffolding for cartilage and bone [53-56]. 
 Despite their enormous potential as tissue scaffolding, electrospun 
fibers possess some limitations. Although the fibers physically resemble the 
ECM molecules, their functionality in terms of biological recognition and 
biochemical composition is lacking. Furthermore, integration of the cells or 
tissue with the electrospun scaffolds is far from ideal. One major factor is the 
lack of cellular infiltration into the scaffold’s architecture. This fact limits the 
true tissue engineering potential of electrospun scaffolds. This thesis aims to 
tackle these two major issues by creating a more biologically relevant fibrous 
structure via collagen compositing and incorporating GAG molecules in an 







Periosteum and bone healing 
 
The periosteum is a thin sheath of fibrous connective tissue covering all parts 
of the bone except where cartilage is present. Native periosteum is composed 
of two layers: inner cambium layer and outer fibrous layer. The fibrous layer 
consists of dense collagenous connective tissue plus fibroblast into which are 
anchored the tendons, ligaments and surrounding connective tissue. The 
cambium layer houses a population of osteoprogenitor cells which have the 
capacity to differentiate into osteoblasts, the main bone forming cells. These 
two layers of the periosteum are critical in the maintenance of homoeostasis 
and regeneration of bone [57]. Osteochondroprogenitor cells in the cambium  
 
 
Figure 3. The periosteum is a fibrous connective tissue covering most outer 
parts of the bone (A). It is distinguished into two main components, the fibrous 
collagenous layer (marked f in B and C, Masson’s Trichrome stain) and the 
cambium layer (marked c in B and C, H & E stain). These two layers are 










layers are known to initiate the earliest formation of bone after fracture [58]. 
Although the fibrous layer does not play a direct role in the process of bone 
repair, it acts as an important limiting layer controlling and restricting the 
extent of bone formation [59]. Networks of blood vessels and nerve fibers are 
present and penetrate the underlying bone tissue via the periosteum. 
 Apart from providing the underlying bone with blood supply, sensory 
feedback and remodeling function during normal physiological function of 
bone, the periosteum plays an important role in the fracture healing and bone 
formation after injury or trauma. Committed osteoprogenitor and 
undifferentiated mesenchymal cells present in the periosteum contribute to 
the process of fracture healing by recapitulation of embryonic 
intramembranous and endochondral ossification [60]. Combined with the 
contribution from bone marrow and the surrounding tissue, the state and role 
of the periosteal tissue is pivotal in the formation of a fracture callus, new 
woven bone and finally remodeled mature lamellar bone. It was found that 
rupture or avulsion of the periosteum surrounding the bone fracture would 
cause the loss of the periosteal tube bridging and hematoma. This results in a 
subsequent impaired fracture healing process and fibrous or delayed union of 
bone [61]. 
 Whole periosteal tissue grafting is currently being explored as an 
alternative for the repair of bone defects and cartilage damages. Similar to 
any other organ/tissue transplantation, whole periosteal grafts serve as a cell 
source, scaffolds for delivering and retaining the cells and a source of local 
growth factors essential for regeneration [62]. Periosteum has been used for 
biologic resurfacing arthroplasty in humans and these periosteal grafts have 
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been shown to adequately repair articular damage and osteochondral defects 
[63]. Experiments using grafted periosteum in the rabbit model have been 
shown to undergo endochondral ossifications during the process of bone 
regeneration and were able to regenerate the rabbit mandibular head [64, 65]. 
Furthermore, a combination of periosteum flaps with bone grafting revealed 
superior new bone formation compared to either bone graft or periosteal graft 
alone [66, 67].  
 Although they have been fairly promising, graftings are not without 
limitations. Autografting poses limitations of donor site morbidity, supply 
shortage and unpredictable resorption of graft, while allografting poses 
immunogenic rejection and possible disease transmission [68]. Tissue 
engineering a substitute for the periosteum could be the way to circumvent 

















Electrospinning of PCL and collagen 
 
Poly (-caprolactone) or PCL is a member of the biodegradable thermo-plastic 
polyester family. Its glass transition temperature (Tg) and melting temperature 
(Tm) are approximately -60 oC and 60 oC, respectively. Similar to other 
biodegradable polyesters such as polylactides and polyglycolides, PCL 
undergoes degradation via hydrolysis of its ester backbone. However, due to 
its relatively more hydrophobic nature and surface hydrolysis degradation 
mechanism, PCL degrades slower than polylactides and polyglycolides. Thus, 
it is an attractive candidate for the exploitation as long term biodegradable 
implants. Several methods have been investigated to fabricate biodegradable 
devices and implants made from PCL and its composites. One of these 
methods is electrospinning. Electrospinning PCL creates structures with 
features that were previously unattainable using any other method. For 
example film cast PCL lacks the surface roughness and porosity for proper 
cellular attachment, while rapid prototyped PCL scaffolds have feature sizes 
much larger than the native ECM. 
 The electrospinning of pure PCL fibrous structures and their 
exploitation as cell substrates or tissue engineering scaffolds have been 
widely reported. Yoshimoto et al demonstrated the potential of a non-woven 
PCL electrospun mesh as an artificial substrate for bone engineering by 
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combining the fibrous structure with MSC and dynamic culturing method[56]. 
Similarly, electrospun PCL meshes have been reported to favorably sustain 
the growth and phenotype of chondrocytes in vitro judging from the 
expression of chondrogenic genes such as collagen type II, IX and aggrecan 
[55]. Furthermore, deposition of cartilage-like matrix on the electrospun mesh 
was comparable to the cell-pellet culture method, a conventional benchmark 
for cartilage tissue culture [69]. Nisbet et al reported the prospective usage of 
electrospun PCL meshes as neural tissue engineering scaffolds when neural 
stem cells adhered, proliferated and differentiated into oligodendrocytes on 
the fibrous substrates [70]. 
 An apparent recent trend in the application of electrospinning technique 
for the fabrication of biomedical materials is the shift towards composite 
materials. Incorporation of natural polymers such as collagen, gelatin, 
chitosan or ceramics such as hydroxyapatite (HAp) into synthetic polymers is 
often directed at the creation of specialized and more biologically relevant 
materials. Composite scaffolds of natural-synthetic materials offer desired 
mechanical and manufacturing properties while retaining bioactive properties 
[6, 7]. A recent study using electrospun PCL mesh revealed improved 
proliferation and characteristic cellular elongation of Schwann cells when 
chitosan was blended into the nanofibrous substrate [71]. Similarly, presence 
of gelatin on the surface of PCL electrospun mats enhanced spreading, 
proliferation and expression of endothelial cells (EC) specific markers such as 
PECAM-1, ICAM-1 and VCAM-1 indicating a more favorable surface for EC to 
grow and maintain function compared to bare PCL [72]. Incorporating nano-
ceramic fillers of CaCO3 and HAp into electrospun PCL nanofibers 
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demonstrated negligible toxicity and favorable cellular response from 
osteoblasts and fibroblast [73]. 
 Another material recurrently incorporated into the formulation of 
composite materials is collagen. Its inclusion in or onto biomaterials has been 
postulated to increase bio-functionality of tissue engineering scaffolds. For 
example, physical modification of electrospun scaffolds’ surface with collagen 
has been shown to enhance the attachment, spreading and viability of EC 
[74]. Similar results were observed with human dermal fibroblast cultured on 
collagen and PCL blend mix nanofibers mesh [75]. Grafting of short peptide 
sequences of type I collagen onto scaffolds were shown to modulate  
 
 
Figure 4. Electrospinning technique was used to fabricate fibrous PCL and its 
composite with collagen. A conventional setup (A) consists of a syringe pump 
that regulates material flow, a high voltage power supply to generate an 
electric field and a charged capillary from which polymer is ejected. A non-
woven mesh is collected over time (B – PCL mesh, C – PCL and collagen 
blend mesh) as a result of this process. 
 
osteogenic differentiation of bone marrow derived progenitor cells [76]. The 
phenotypes of bone and cartilage cells have also been shown to be 
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modulated when collagen was covalently immobilized onto PLGA scaffolds 
[77, 78]. In light of the bioactive nature and its potential role mediating 
osteogenic repair by mesenchymal progenitor cells, collagen was included in 
the design and fabrication of our electrospun fibrous mesh for a periosteal 
substitute. 
 Electrospinning technique was able to fabricate fibers of sub-micron 
diameters in a simple, rapid and reproducible fashion. PCL and its blend with 
collagen (PCL/Col) were fabricated using an in-house conventional 
electrospinning setup (Fig. 4A). Deposition over a pre-determined period of 
time resulted in tough yet flexible nanofiber sheets (Fig. 4B, C) that could be 
handled for downstream applications. Morphology and size distribution of PCL 
and PCL/Col nanofibers were studied using an electron microscope. The 
presence of collagen on the surface was also studied via 
immunofluorescence. Their results are shown in Figure 5. Three different 
collagen compositions by weight were used for electrospinning: 20% (Fig. 5C, 
D), 40% (Fig. 5E, F) and 60% (Fig. 5G, H) to study the effect of increasing 
collagen amounts in the fibers. Morphologically, fibers from all groups 
appeared similar. However in PCL/Col groups, a second much finer fiber 
distribution was observed. In terms of fiber diameters, PCL had a size 
distribution of 559 ± 254 nm while those with 20%, 40% and 60% collagen 
had 575 ± 90, 513 ± 83 and 562 ± 96 nm, respectively. Addition of increasing 
amounts of collagen into the electrospinning mix did not significantly change 
the fiber size distribution. The added collagen revealed surface localization 
regardless of composition (Fig. 5D, F, H), whereas there was none on PCL 




Figure 5. Electrospun fibers of sub-micrometer diameters were produced from 
PCL and its collagen composite (PCL/Col) with varying collagen content. 
Electron micrographs revealed similar fiber morphology with a tendency for 
larger diameters when more collagen by weight was introduced (A – PCL 
only, C – PCL/Col 20%, E – PCL/Col 40%, G – PCL/Col 60%). Localization of 
collagen was studied using immunofluorescence against collagen type I. 
Collagen was found to be presented on the fibers’ surface in all preparations 
except for pure PCL (B – PCL, D – PCL/Col 20%, F – PCL/Col 40%, H – 




preferentially and exclusively bound to the surface (i.e. co-axial collagen and 
PCL fiber) or was uniformly mixed throughout. 
 The effect of collagen inclusion was also studied on the resulting 
mechanical properties of the electrospun mesh (Figure 6). Addition of 20%, 
40% and 60% collagen into the electrospun fibers decreased the structural 
Young’s modulus of PCL by 42.8%, 70.1% and 71.8% respectively (Fig. 6A). 
A collagen content of more than 20% revealed significant deterioration (about 
50%) in the resulting mesh’s modulus. A similar trend was observed with the 
ultimate stress of the electrospun meshes (Fig. 6B). Ultimate stress of PCL 
was compromised by 26.9%, 70.8% and 76.1% when 20%, 40% and 60% 
collagen was added respectively. A further 65% reduction was observed when 
40% and 60% collagen was added compared to PCL/Col 20%. Interestingly, 
an increase of 26.4% in ultimate strain was seen when 20% collagen was 
added into PCL (Fig. 6C). Similar increment was obtained when 40% collagen 
was used. A decrease was observed however when 60% collagen was used. 
Its ultimate strain was 12% lower compared to pure PCL and 30.7% lower 











Figure 6. Mechanical tensile tests were carried out to examine the strength 
and the effect of varying amounts of collagen towards the electrospun fibers. 
Graphs A to C illustrate the effects of composition towards Young’s modulus, 
ultimate stress and ultimate strain of the electrospun meshes. Representative 
stress-strain curves of all four fiber preparations are shown in D. In general, 
addition of increasing amounts of collagen was found to decrease Young’s 
modulus and ultimate stress, and increase ultimate strain of the material. 
Asterisks in A-C indicate significant differences between samples (p<0.05). 
 
 An apparent effect of the collagen inclusion into the PCL matrix was 
the collagen coating of the individual fibers. This may prove beneficial as 
direct contact with cells and tissues are possible. However, collagen inclusion 
may have caused the formation of domains or phases of the two dissimilar 
materials introducing discontinuity which weakened the fibers relative to pure 
PCL. Such diminution of the scaffold’s strength was also observed when 
collagen and gelatin were introduced into PCL nanofiber meshes [79, 80]. The 
interface between these phases may act as a stress concentrator and fracture 
initiator and is more prominent in very dissimilar material mixtures such as 
polymer-ceramic systems (e.g. PCL-CaCO3) [81]. Thus, selection of 
appropriate systems in the fabrication of composite materials is vital to 
balance the necessary mechanical properties and bioactivity of scaffolds. 
Further studies were conducted using PCL/Col 20% as the presence of 
collagen on the fibers’ surface will provide the added bioactivity with less 






Figure 7. Quantitative analysis of collagen on the surface of PCL/Col 20% 
fibers was performed by immunofluorescence accompanied by electron 
microscopy. Collagen was still detected on the PCL/Col 20% fiber surface 
after in vitro incubation in DMEM for 2, 4 and 7 days (A-C). A three hour 
collagenase digestion however rendered the surface collagen undetectable 
(D). No morphological changes were visible up to 7 days (E-G) while 
collagenase treatment did cause some visible degradation (H). Differential 
scanning calorimetry (DSC) analysis was performed on PCL and PCL/Col 
20% electrospun fibers (I). It was observed that the addition of collagen into 
the structure changed the enthalpy for melting indicating a change in 
crystallinity. Bar is 50 m in A-D; 5 m in E-H. 
 
 Analysis of the collagen presence on the PCL/Col 20% fibers in vitro 
after 2, 4 and 7 days are shown in Figure 7. Qualitative observations revealed 
that collagen remained on the surface for at least one week in cell culture 
media (Fig. 7A-C). No morphological differences were observed as well in the 
appearance of the fibers (Fig. 7E-G). However, when the electrospun 
nanofibers mesh was treated with collagenase, surface collagen was 
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eradicated (Fig. 7D). The collagen type I antibody used to detect the surface 
collagen only recognizes native (helical) form of collagen type I. Similarly, the 
collagenase enzyme that was used also recognizes unique sequences that 
are present in triple-helical collagens. These results indicated that some form 
of intact and native form of triple-helical collagen type I was still present on the 
fibers’ surface. Thermal analysis of the electrospun PCL and PCL/Col 20% 
showed approximately 50% reduction in enthalpy of melting when collagen 
was added while not significantly affecting its peak melting temperature (Fig. 
7I). The result suggested that addition of collagen into the PCL matrix reduced 
the crystallinity of the composite’s structure. 
 A study on the degradation of the PCL/Col electrospun mesh was 
performed via DSC and GPC after one and three months of in vitro culture 
[82]. Peak melting temperature increased about 2 oC after one and three 
months compared to as-spun state. An accompanying increasing trend in 
enthalpy of melting suggested an increase in crystallinity of the fiber’s 
structure. PCL degradation was observed as a reduction of about 12% in 
molecular weight occurred. Culture of smooth muscle cells for five weeks on 
the PCL/Col meshes showed excellent viability and proliferation [82]. These 
results illustrated the potential of PCL/Col 20% electrospun meshes as cell 
substrates in tissue engineering scaffolds. Thus this material composition was 





In vitro cell culture characterization by using pig 
primary bone marrow cells 
 
As a periosteum substitute, an electrospun mesh should be able to 
temporarily replace the function of the lost native tissue. One critical feature of 
the periosteum is its function as a mesenchymal progenitor reservoir which 
can be activated to assist bone repair in the event of trauma. Thus the ability 
of PCL/Col electrospun fibers to support attachment, proliferation and 
differentiation of mesenchymal progenitor cells must be evaluated. This 
section describes the study conducted to assess the osteo-conductivity of 
PCL/Col nanofiber mesh towards mesenchymal progenitor cells of bone 
marrow origin. The bone marrow has been known to host a population of 
progenitor cells capable of differentiating into mesenchymal lineages[83-86]. 
These cells have been shown in vitro and in vivo to differentiate into 
myocytes, adipocytes, chondrocytes and osteoblasts. Promising clinical 
results were observed when these progenitor cells were injected directly into 
the defect site [87, 88]. However, more severe defects often require a support 
structure or scaffolding in conjunction with cell implantation for proper 
regeneration to take place. In these cases, favorable interactions between the 
biomaterial and the progenitor cells are crucial. 
 Cellular attachment and morphology on the electrospun PCL/Col and 
PCL control meshes are shown in Figure 8. Osteogenic media containing 
dexamethasone, ascorbic acid and -glycerophosphate was used for in vitro 
culture (induced group) to promote differentiation towards bone lineage. For 
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comparison purposes, un-supplemented growth media (un-induced group) 
was included in the study for both scaffold compositions. Bone marrow cells 
(BMC) attached and proliferated on scaffolds in all four study groups. 
Spreading of the cells however, was more pronounced on PCL/Col scaffolds 
compared to a more rounded morphology on pure PCL nanofibers (Fig. 8A).  
 
 
Figure 8. Cellular attachment and morphology of the bone marrow cells 
(BMC) were observed on both PCL and PCL/Col electrospun scaffolds. After 
one day of seeding, cells were more rounded on PCL due to a greater 
hydrophobic nature compared to PCL/Col (A). By 14 days of culture, 
clustering of cells were observed on PCL scaffolds (both induced and un-
induced) while a more uniform cell distribution was seen in PCL/Col (B). Dy 
28 days, full coverage of the surface was observed in all scaffolds except PCL 




On the PCL scaffold, cell clustering occurred due to the hydrophobic nature of 
the surface. At 14 (Fig. 8B) and 28 days (Fig. 8C) of in vitro culture, qualitative 
differences in proliferation were observed on the four types of scaffolds. 
Induction groups showed highest cell density followed by un-induced PCL/Col 
and lastly the un-induced PCL group. Complete coverage of the scaffolds’ 
surface was observed after 28 days in all groups except un-induced PCL. 
 Cellular proliferation was assayed qualitatively by DNA amount 
measurements of the BMC cultured on PCL and PCL/Col scaffolds (Fig. 9A). 
BMC proliferated on all scaffolds albeit with differing rate. Overall, PCL/Col 
scaffolds, with and without osteogenic supplements, were able to support 
BMC proliferation compared to PCL. The cell number reached a plateau at a 
much lower level in PCL nanofiber groups. Without osteogenic supplements, 
PCL nanofiber mesh was not able to support significant cellular proliferation. 
The spreading and proliferation of BMC were modulated by the surface bound 
collagen. Binding of cells to collagen, presumably via integrins, has been 
reported to trigger pathways that lead to actin-mediated cellular spreading[89] 
and possibly the activation of cbfa1 transcription factor, initiating osteoblastic 
phenotype development [90-92]. Supplementation of the media with 
osteogenic inductive chemicals accelerated the differentiation process based 
on the steeper DNA amount profile. This proliferative phase is considered as 
the earliest principle period in osteoblast developmental sequence before 
matrix development and mineralization [93, 94]. A significant reduction in cell 
number occurred in PCL/Col induced group after two weeks of culture. 
Maturation of the bone-like tissue was responsible for this as indicated by the 




Figure 9. Cellular DNA amount was quantified to study the differences in 
cellular proliferation on four scaffold groups (A). Cellular proliferation was 
more pronounced on PCL/Col compared to PCL with the same media 
composition. Effects of osteogenic induction could be seen in the early burst 
of proliferation in PCL/Col and PCL groups. Induced BMC on PCL/Col 
showed the highest proliferation rate which peaked and declined after two 
weeks of culture. Osteogenic differentiation and maturation of the bony neo-
tissue was evident from the calcium (Ca) mineral deposition on the PCL/Col 
scaffolds as assayed by SEM/EDX (B). This tissue maturation and cellular 
senescence may be responsible for the apparent decline of cell numbers. Bar 
represents 5 m in B. 
 
 Tissue formation and bone-specific matrix deposition after 14 and 28 
days of culture on the electrospun nanofiber scaffolds were studied via 
histology and immunohistochemistry (Fig. 10). Osteogenic induction of the 
BMC caused thick and multi-layered tissue to form on the electrospun 
PCL/Col scaffolds. This was in contrast with PCL scaffolds where cells existed 
as a monolayer throughout the culture period. The tissue formed on PCL/Col 
after in vitro culture exhibited strong collagen type I, osteopontin and 
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osteocalcin staining. The deposition of specific proteins such as collagen type 
I and osteopontin is central in providing the proper environment for the  
 
 
Figure 10. Formation of new tissue on electrospun PCL and PCL/Col 
nanofiber scaffolds was studied via histology and immunohistochemistry. 
Marked contrast was observed after 14 and 28 days of in vitro culture with 
multi-layered tissue formation on PCL/Col induced group. BMC on PCL 
scaffolds remained as a monolayer throughout 28 days. Osteogenic marker 
proteins; collagen type I, osteopontin and osteocalcin were present in 
PCL/Col group with mineralization at 28 days. Marginal expression of collagen 
type I and osteopontin was observed on PCL although osteocalcin and 
mineralization were not present. This signified that the formation of mature 




mineralization phase [94]. Calcium deposition as observed through Alizarin 
Red S staining was only present after 28 days of culturing on PCL/Col 
induced group. On the PCL nanofiber group, BMC showed weaker expression 
of collagen type I and osteopontin while calcium deposition was not present at 
all. Mineralization and secretion of osteocalcin, which has been reported to be 
important in maintaining bone homeostasis, are seen as hallmarks of mature 
bone-like tissue formation. The lack of these characteristics in PCL scaffolds 
indicated that further tissue maturation did not occur. 
 From the results outlined above, inclusion of collagen into the 
electrospinning mix of PCL created a nanofiber scaffold superior in terms of 
cellular attachment, proliferation and its osteo-conductive properties towards 
BMC. To further study the potential of PCL/Col electrospun mesh as bone 
tissue engineering scaffolding material, tubular constructs were created by 
integrating the electrospun fibers with osteogenic cell sheets. As a preliminary 
attempt to create a long bone analog, the constructs were cultured in vitro for 
two months in a dynamic environment to foster better tissue formation (Fig. 
11A). A schematic representation of the tubular constructs is shown in Fig. 
11B. Osteogenic cell sheets were used in this study as a cell delivery method 
due to their intact cell-to-cell junctions and extracellular matrix [95, 96]. These 
cells remained viable during the course of the experiments and formed 
constructs of 1-2 mm wall thickness and 6 mm diameter. Mechanical analyses 
revealed that the constructs were stronger in the radial direction compared to 
the axial direction (Fig. 11C). Modulus of the construct was 21 MPa, 20 times 
higher than the control value of 1 MPa. In the axial direction, construct 
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stiffness and modulus were 0.86 N/mm and 2.4 MPa respectively. These 
values were 4-7 times higher than the controls (0.11 N/mm and 0.6 MPa).  
 
 
Figure 11. Further studies were conducted by culturing BMC on PCL/Col 
nanofiber meshes in a dynamic environment using a spinner flask at 30 RPM 
speed (A). Inset in A shows the final constructs after two months of culture. 
The BMC were harvested as cell sheets and wrapped around PCL/Col 
meshes supported on a glass pipette to create tubular constructs (B). 
Compressive tests on the constructs after two months of dynamic culturing 
were performed and results are shown in C. Integration of the cell sheet with 
the electrospun meshes improved their mechanical strength. Mechanical 
anisotropy was observed as the tubular constructs were stronger in the radial 
direction compared to axial direction. Bar in A represents 1 cm. 
 
 After one month of dynamic culturing, thick tissue formation was 
observed in the constructs (Fig. 12A, B). Two distinct tissues were seen, a 
middle thin layer which stained heavily with eosin and a thicker fibrous tissue 
on the outer and inner side of the electrospun mesh. After two months of 
culture, three layers of tissue were observed, an outer layer (OL), a middle 
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layer (ML) and a thick inner fibrous tissue (FT) (Fig. 12C, D). Safranin-O 
staining revealed cartilage-like matrix in ML while minimum staining was 
observed on the other layers. Further investigations via immunohistochemistry 
for bone specific matrix revealed heavy calcification (Fig. 13A, B) and 
expression of osteocalcin in ML (Fig. 13E, F). Collagen deposition was 
expressed with marginal differences between the layers (Fig. 13C, D). From 
the results, it was concluded that bone-like tissue formed in the tubular 
constructs. An endochondral ossification pathway was likely to ensue in some 
parts of the constructs as chondrocytes-like cells in vacuoles and cartilage 
matrix were present along with mineralization and bone specific protein, 
osteocalcin. BMC were thought to first differentiate into chondrocytes followed 
by matrix mineralization to form bony tissue. Calcification in the structure 
could in turn explain the increase in the apparent stiffness and modulus of the 
constructs. 
 Although the results presented above showed promising potential of 
the PCL/Col electrospun meshes towards the utilization in bone tissue 
engineering, their two dimensional sheet-like nature will likely limit their 
downstream applications. To fully exploit its potential, a more 3D electrospun 
fibrous structure which allows infiltration of cells and tissues in vitro and/or in 
vivo is critical. The next chapter will present approaches and developments to 




Figure 12. Histological analyses were performed via H & E and Safranin-O 
staining on the one and two months old constructs to study tissue formation. 
After one month culture the constructs showed thick tissue formation on both 
sides of the mesh (A, magnified region in B). After two months, three distinct 
layers were observed: outer layer (OL), middle layer (ML) and an inner fibrous 
tissue (FT) (C, magnified region in D). Strong Safranin-O staining revealed 
development of cartilage-like tissue in the middle layer adjacent to the 








Figure 13. Osteogenic tissue formation in the two months old tubular 
constructs were assayed by Alizarin Red S (ARS; A, region magnified in B) 
staining for calcium and immunohistochemistry for collagen type I (Col I; C, 
region magnified in D) and osteocalcin (OCN; E, region magnified in F). The 
middle layer tissue exhibited a strong presence of calcium and osteocalcin. 
Collagen staining was moderately observed throughout the structure. Bar 







Materials and methods 
 
Materials and reagents 
All materials and reagents were purchased from Sigma Aldrich (St. Louis, 
MO, USA) unless otherwise stated. Porcine collagen particulates were 
obtained from Nippon Meat Packers Inc. (Osaka, Japan). Chloroform used as 
an electrospinning solvent was from EM Science (Gibstown, NJ. USA). Cell 
culture media and reagents were purchased from Gibco (Grand Island, NY, 
USA). Trypsin 0.25% solution was purchased from Hyclone (Logan, UT, 
USA). Mouse monoclonal antibody against osteocalcin and rabbit polyclonal 
antibody against osteopontin were purchased from QED Bioscience (San 
Diego, CA, USA) and Abcam (Cambridge, UK), respectively. FITC-labeled 
secondary antibody against mouse IgG and developmental kit for HRP 
immunohistochemistry were purchased from DAKO Cytomation (Glostrup, 
Denmark). 
 
Scaffold fabrication and characterization 
Electrospinning. Electrospun PCL meshes were made by dissolving PCL 
pellets in a solvent mixture of HFIP:Chloroform with a 4:1 volume ratio to 
make a 12.5% w/v concentration. For PCL/Col 20%, 40% and 60% meshes, 
2.5% w/v, 5% w/v and 7.5% w/v of collagen was added respectively, replacing 
the same weight of PCL to maintain total solute concentration. The polymer 
solutions were loaded into a 5 mL syringe mounted on a syringe pump. 
Polymer was fed to a metal capillary (21-Gauge needle) at a constant rate of 
0.75 mL/hr. The metal capillary was charged to 10 kV to initiate 
  
40
electrospinning. Grounded aluminum foil was placed 15 cm below the tip and 
was used to collect the fibers. The non-woven fibers were then dried in a dry 
cabinet. 
 
Scanning Electron Microscope (SEM). Dried fibrous meshes were cut into 1 
cm x 1 cm squares for SEM viewing. Samples were mounted on SEM stubs 
and sputter coated with Au using BALTEC glow discharge sputter coater 
(Liechtenstein). Viewing was done with a JEOL 5600 electron microscope 
system under 10 kV accelerating voltage. 
 
Immunofluorescence. Dried fibrous meshes were cut into 1 cm x 1 cm 
squares and were incubated with mouse monoclonal antibody against porcine 
collagen type I at 4 oC for 16 hours. Following washing with phosphate-
buffered saline (PBS), the samples were incubated with FITC-labeled 
antibody against mouse IgG at ambient temperature for 30 minutes. Viewing 
was done using an Olympus FV500 laser scanning confocal microscope 
(LCSM) system. Collagenase treated meshes were obtained by incubating the 
fabricated meshes in 0.1% collagenase type I solution in PBS at 37 oC for 
three hours. 
 
Tensile test. Tensile tests were done on the meshes previously cut into 3.5 
cm by 1 cm strips using an Instron tensile tester with 100 N load cell. All tests 
were done in PBS immersion at 37 oC with a crosshead speed of 10 mm/min 
until scaffold failure. Calculation for stress was performed using the nominal 




Differential Scanning Calorimetry (DSC). Wet samples for electrospun 
meshes (5-15 g of mass) were hermetically sealed in a 50 L aluminum pan 
and then heated at a constant rate of 5 oC/min in the temperature range of 15-
90 oC using a 822e DSC (Mettler Toledo International Inc., Singapore). An 
empty aluminum pan was used as a reference. Temperature peaks and 
energy involved for the phase transitions were recorded. 
 
Cell culture and in vitro osteogenic differentiation 
BMC culture. BMC were isolated from the iliac crest of Duroc-Yorkshire pigs 
weighing between 45-50 kg and aged 16-18 weeks. Briefly, a 20 mL syringe 
containing 1.5 mL of 5000 IU/mL heparin was used to extract 10-15 mL of 
bone marrow aspirate. The aspirate was then gently mixed and placed into 
tissue culture flasks. Approximately 3 mL of the aspirate was plated on a T150 
culture flask containing 25 mL expansion culture media (DMEM supplemented 
with 10% FBS and 1% antibiotics). The cells were then cultured in a heat 
sterilizable humidified incubator with 5% CO2 atmosphere (Binder GmbH, 
Tuttlingen, Germany) at 37 oC. Sub-culturing of cells was performed by 0.25% 
Trypsin enzymatic digestion once cells reached 70-80% confluency. Passage 
2-3 cells were used in these studies.  
 
Scaffold seeding and culture. BMC (20,000 cells/cm2) were seeded on 
electrospun meshes cut into 1.5 cm by 1.5 cm squares. The scaffolds were 
previously ethanol sterilized, UV irradiated for 15 minutes and conditioned 
overnight in culture media. PCL and PCL/Col meshes were used in this study 
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and each material is divided into two sub-groups: induced and un-induced. A 
total of four study groups were present. Induced groups were cultured in 
media supplemented with osteogenic differentiation factors (10 nM 
dexamethasone, 50 M ascorbic acid 2-phosphate and 10 mM -
glycerophosphate) while un-induced groups were maintained in basal media. 
Experiments were conducted up to four weeks with weekly time-points for 
various assays. 
 
Cell proliferation assay. At pre-determined time-points, cell-scaffold constructs 
were collected from four study groups. Samples were then incubated with 
enzymatic solution of 0.1% w/v trypsin and collagenase for one hour at 37 oC. 
Total DNA amount in the resulting suspensions was measured using the 
PicoGreenTM dsDNA quantitation assay in accordance to the manufacturer’s 
protocol. Fluorescence measurements were done at 485 nm (excitation) and 
535 nm (emission) using a TECAN spectrophotometer (Salzburg, Austria). 
 
Cell morphology and attachment assay. At pre-determined time-points, 
samples were collected from all four groups and were fixed with 2.5% 
glutaraldehyde. The samples were then serially dehydrated using an ethanol 
gradient followed by drying. Prior to SEM observations, the cell-scaffold 
constructs were gold sputter coated. Viewing was performed using a JEOL 
electron microscope system under 10 kV accelerating voltage.  
 
Histology and immunohistochemistry. Prior to histology and 
immunohistochemistry, samples were collected and sectioned using a cryo-
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microtome (10 m thickness of each section). General tissue formation was 
studied by hematoxylin and eosin (H & E) staining of the constructs. 
Immunohistochemical methods were used to study specific matrix protein 
deposition (i.e. collagen type I, osteopontin and osteocalcin). All 
immunohistochemical staining were developed using a HRP-DAB 
development kit. Matrix mineralization of the constructs was studied using 
alizarin red S staining. 
 
Engineering tubular cell-scaffold constructs 
Creation of tubular constructs. Tubular cell-scaffold constructs were produced 
by wrapping osteogenic cell sheets onto PCL/Col meshes which had been 
pre-seeded with BMC. Osteogenic cell sheets were obtained by culturing 
BMC in osteogenic media for 2 to 3 weeks. The osteogenic cell sheets were 
detached from the culture substrates mechanically via the use of cell 
scrapers. PCL/Col electrospun scaffolds of 2 cm by 2 cm were rolled to form 
cylindrical shape with a diameter of 6 mm. The scaffolds were seeded with 
BMC on both sides (approximate density was 20,000 cells per cm2) and then 
further wrapped with the cell sheet to form the tubular constructs. Plastic 
sterile serological pipettes were utilized as a substrate for the rolling up 
process to maintain the tubular shape of the constructs. The tubular 
constructs were then cultured in a static condition for one week in a humidified 
incubator, 5% CO2 atmosphere under osteogenic induction condition (10 nM 
dexamethasone, 50 M ascorbic acid 2-phosphate and 10 mM -
glycerophosphate). The constructs were then transferred into spinner flasks 
for dynamic culturing under osteogenic induction conditions for one to two 
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months. The tubular constructs were suspended via a thin wire to the spinner 
arms such that that the long axis of the constructs was parallel to the ground. 
The spinner flasks were filled with 100 mL of media and were set to a speed 
of 30 RPM. In this manner, culture media was allowed to flow through the long 
axis exposing both the inner and outer surface of the constructs to fluid shear 
stresses. As controls, PCL/Col tubes without cell-sheet wrapping were 
cultured as well as controls. At one and two month time-points, samples were 
collected for histological and mechanical analyses. 
 
Histology and immunohistochemistry. After 4 and 8 weeks, constructs were 
collected and fixed in 3.7% formaldehyde. They were then dehydrated and 
embedded in paraffin after decalcification in 30% formic acid. Sections of 10 
m thickness were obtained using a Leica microtome. H & E staining, 
Safranin-O, Alizarin Red S and immunohistochemical methods were utilized 
to study the tissue and bone specific matrix proteins (collagen type I, collagen 
type II and osteocalcin). HRP-DAB development kit from DAKO was used to 
visualize the staining. 
 
Compression test. Collected samples were mounted on a Bose material 
testing system (Bose, CA, USA) fitted with a 225 N load cell. Specimens were 
kept wet by dropping PBS prior to test. A crosshead speed of 2 mm/min was 
used and a compression load of up to 20 N was applied. Testing on the axial 
direction was done by using an indenter. The stiffness value was calculated 
from the linear region of the load-elongation curve. The modulus was 




Statistical analysis. Statistical analysis of data was performed by using a two-
























Osteo-conductivity comparison between collagen 
and gelatin PCL composites 
 
 
Collagens, due to their stature as essential components of many cell and 
tissue niches throughout the body, have been manipulated and utilized in the 
creation of bio-devices. Consequently, the creation of fibrous scaffolds made 
of collagens and their derivatives or composites became an attractive and 
feasible option with the electrospinning method. In 2001, Huang et al reported 
the possibility of creating a composite fibrous mesh of PEO and collagen type 
I using the electrospinning technique [97]. Ever since then, interests in 
electrospun collagens were intensified as reflected by the number of 
published reports. 
 A major concern however, comes from the resulting state of the protein 
after the electrospinning process. Some of the published reports involved 
organic solvents in the electrospinning process, which were more crucial 
when synthetic polymers were used in the creation of composite scaffolds [41, 
44, 98-101]. Exposure of protein molecules to organic solvents such as 
1,1,1,3,3,3-hexafluoro-2-propanol (HFIP) or 2,2,2-trifluoroethanol (TFE) has 
been reported to cause denaturation of their native structure [102-104]. Thus, 
electrospinning using these types of solvents may cause collagen molecules 
to lose their ultra-structural arrangement and triple-helical conformation. 
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Independent studies reported by Yang et al and Zeugolis et al confirmed that 
a significant loss of collagen structure occurred after HFIP exposure [105, 
106]. The conversion of collagen into its denatured state, gelatin, may explain 
the water solubility of the resulting electrospun materials [44, 99, 107]. 
 Structural alteration of collagen into gelatin would raise the issue of 
justifying collagen inclusion into tissue engineering scaffolds produced via 
electrospinning. Denaturation (partial or full) into gelatinous molecules would 
prevent the exertion of collagen bioactivity due to the loss of protein/cell 
binding motifs. A point to note however, is that gelatin has also been 
extensively exploited in the biomedical field as drug delivery vehicles, surface 
coatings and cell/tissue substrates due to its own unique properties [108-110]. 
Thus, it is of our interest to investigate and compare the performance of 
collagen and gelatin composites of electrospun PCL meshes. 
 Fabrication of collagen and gelatin composites of PCL meshes were 
performed by using similar electrospinning parameters. Weight percentage of 
natural materials in the composite i.e. gelatin and collagen was kept constant 
as well (20% w/w). SEM images of the resulting electrospun PCL, PCL/Col 
and PCL/Gel meshes are shown in Fig. 14 with the accompanying collagen 
type I immunofluorescence images. Morphologically, fibers were uniform and 
similar in average diameter regardless of composition. Immunofluorescence 
using a specific antibody against native collagen type I revealed surface 
localization of the proteins on the electrospun PCL/Col fibers’ surface. The 
assay did not detect the presence of collagen on the PCL/Gel fibers (Fig. 
14C). As the Col I specific antibody only recognizes intact triple helical, non-
denatured proteins, these results suggested some preservation of native 
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collagen structure in PCL/Col fibers. It is therefore believed that the included 
collagen existed in partly denatured and partly native conformation although 
the extent of each is unknown. Gelatin molecules in PCL/Gel did not possess 
the antibody recognition sites as they were completely denatured due to the 
acid/alkali treatment common in the preparation of gelatin [111]. 
 
 
Figure 14. Qualitative differences in morphology and surface properties of 
PCL, PCL/Col 20% and PCL/Gel 20% were studied using 
immunofluorescence against collagen type I (A-C) and scanning electron 
microscopy (D-F). PCL/Gel sample did not posses the collagen type I epitope 
on its surface compared to PCL/Col, indicating total denaturation. 
Morphologically, PCL/Gel fibers showed similar sizes with a larger distribution 
of fiber diameter compared to PCL/Col. Bar represents 50 m in A-C; 5 m in 
D-F. 
 
 Comparisons between collagen and gelatin composites of PCL 
electrospun meshes were taken further by investigating the resulting meshes’ 
mechanical properties. Young’s modulus, ultimate stress and ultimate strain of 
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the electrospun fibers are shown in Figure 15 A, B and C respectively. 
Inclusion of 20% w/w gelatin instead of collagen resulted in significant 
deterioration in elastic modulus, ultimate stress and ultimate strain. Young’s 
modulus decreased 70% compared to PCL/Col and 84% compared to pure 
PCL. A similar trend was observed for ultimate stress, whereby a 25% 
reduction was seen compared to PCL/Col and 46% compared to PCL. 
Substituting collagen with gelatin resulted in a 18% drop of ultimate strain 
compared to PCL/Col. Referring to representative stress-strain curves (Fig. 
15D), PCL/Gel had a smaller area under the curve indicating lower toughness 








Figure 15. Mechanical analyses were performed to study the effects of gelatin 
inclusion into PCL structure towards its Young’s modulus (A), ultimate stress 
(B) and ultimate strain (C). PCL/Col 20% was included as a comparison. In 
general, addition of 20% w/w gelatin into the PCL mesh resulted in a 
significant decrease of Young’s modulus and ultimate stress. The resulting 
PCL/Gel material was found to be significantly weaker than PCL/Col of the 
same weight ratio. Representative stress-strain curves of the three nanofiber 
preparations are shown in D. Asterisks indicate significant differences 




 Although the electrospun fibers alone may not be suitable for load-
bearing applications, examining their mechanical properties may yield crucial 
information on suitability of polymers and possible reason for failures. Addition 
of gelatin into the electrospun fibers tremendously compromised the meshes 
mechanically. The effect was far more significant compared to the addition of 
collagen. This major mechanical deterioration of PCL by gelatin was observed 
in a study by Ghasemi-Mobarakeh et al with 30% gelatin content and even 
more so with 50% PCL-to-gelatin ratio [112]. In other polymer systems such 
as PLLA, PAN and PLGA, inclusion of gelatin has also been reported to 
reduce the resulting mechanical strength of the electrospun meshes [113-
115]. Furthermore, the measured modulus, stress and strain of the 
electrospun meshes are dependent on the testing conditions i.e. wet or dry 
[115]. As all the electrospun meshes were tested under PBS immersion at 37 
oC, this may account for the lower values obtained compared with other 
published results obtained in a dry setting and at an ambient temperature. 
 The difference in mechanical properties between PCL/Col and PCL/Gel 
could be attributed to the different structures the natural polymers (collagen 
and gelatin) assume after electrospinning. Although some degree of collagen 
denaturation occurred, the final state of the protein may have been different 
compared to that of the gelatin composite. Fluorinated alcohols such as TFE 
and HFIP have often been used in the generation of partly denatured 
intermediate protein states because of their ability to disrupt non-covalent 
hydrogen, ionic and hydrophobic bonds [104]. These solvents however have 
also been reported to preserve the helical structure of proteins although to 
differing extents depending on the proteins [116-118]. It was conceivable that 
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the presence of chemical cross-links in the collagen molecules facilitated 
some degree of triple helical conformation preservation in the resulting 
PCL/Col fibers [119]. Type B gelatin molecules however were devoid of 
chemical cross-links due to the harsh alkali treatment during product 
processing. A more crystalline collagen phase may have instigated a 
mechanically stronger composite compared to an amorphous gelatin phase. 
 Comparisons were also performed on the biological performance of the 
electrospun meshes. BMC were used to assay the ability of the meshes to 
support attachment, proliferation and osteogenic differentiation of the 
mesenchymal cells. SEM of BMC attaching on PCL, PCL/Col and PCL/Gel 
are shown in Fig. 16A, B and C, respectively. Qualitative examinations 
revealed no major differences in cellular attachment and spreading between 
collagen and gelatin composites. As previously observed, BMC on PCL 
meshes were rounded in morphology due to un-favorable surface chemistry. 
Albeit through different mechanisms, both collagen and gelatin posses cell- 
 
 
Figure 16. BMC attachment and morphology on PCL (A), PCL/Col 20% (B) 
and PCL/Gel 20% (C) were studied using electron microscopy. Cells attached 
well although a more rounded morphology was observed on PCL as 
previously seen. BMC looked similar in terms of distribution and morphology 
on PCL/Col and PCL/Gel. Bar represents 10 m in all images. 
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adhesion peptide sequences. Denaturation of collagen molecules resulted in 
the dissociation of their triple helical chains into individual  and  chains 
[120]. Cell adhesion towards collagen is mediated through RGD-independent 
integrin association with the triple helical configuration, whereas denaturation 
of collagen into gelatin exposes previously cryptic RGD peptides in the 
structure [121, 122]. 
 Marked differences were also seen on the proliferation profiles of BMC 
on the three electrospun mesh groups (Figure 17). Regardless of composition 
and experimental time-points, supplementation with osteogenic induction 
cocktail (OIC) yielded higher cell numbers than those without. Without the aid 
of OIC (un-induced groups), no significant differences were found at all time-
points between PCL/Col and PCL/Gel meshes, indicating similar BMC 
proliferation rates on the two composites. Both surfaces provided motifs onto 
which integrins could adhere and regulate cellular functions such as 
attachment and proliferation [123, 124]. BMC have been shown to display 
integrins on their cell surface to facilitate attachment to their ECM components 
such as collagens [125]. After one week of culture with OIC (induced groups), 
PCL/Gel mesh had more cells than PCL/Col although the difference was not 
significant. After two weeks cell numbers were more prominent in PCL/Col 
than PCL/Gel, while with the difference became significant after four weeks. 
The differentiation process of the BMC towards the bone lineage was 
responsible for the observed differences in proliferation profile between 
induced and un-induced groups. PCL/Col mesh may have been able to 





Figure 17. BMC DNA profile was assayed via the PicoGreenTM DNA 
quantitation kit. Generally, groups cultured under an osteogenic induction 
environment showed more pronounced cellular proliferation at all time-points. 
Minimum proliferation was seen in the un-induced PCL group. PCL/Col and 
PCL/Gel electrospun meshes allowed more significant cell proliferation.  
 
 
 Throughout the four weeks of in vitro culture, osteogenic gene 
expression i.e. CBFA1, COL1A1, ALP and OCN was assayed using qPCR on 
all groups of scaffolds (Figure 18). BMC gene expressions on PCL un-induced 
meshes were used as baseline values and normalizations for all genes and 
time-points. Looking at the gene expression for core binding factor alpha 1 
protein (CBFA1), it was observed that BMC cultured on PCL/Col showed 
higher levels of expression regardless of time-points (Fig. 18A). Interestingly, 
OIC did not seem to cause any significant effect on the up-regulation of 
CBFA1, indicating greater influence from the meshes’ surface properties. The 
most notable difference was observed at day 7 between PCL/Col and other 
groups followed by a decrease to similar levels at later time-points. Cbfa1 is a 
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transcription factor critical in the early development of the osteoblastic 
phenotype [126, 127]. It has also been reported to be down-regulated during 
the later stages of osteoblast development [128].  
 Early expression of the protein was lower in PCL/Gel relative to 
PCL/Col. The difference in the ability of the collagen composite to better 
initiate and sustain osteogenic differentiation compared to the gelatin 
composite mesh indicated some preservation of bio-functionality of the 
collagen. Structural conservation of the collagen triple helices to a certain 
degree may have allowed the interaction with specific integrins on the cell 
surface critical for osteogenic differentiation. Takeuchi et al reported the 
down-regulation of TGF- inhibition by collagen type I binding to 21 integrin 
sub-units allowing osteogenic differentiation to take place [90]. Furthermore, 
this specific collagen I-21 integrin binding activates and up-regulates the 
production of cbfa1 [91]. In a study published by Reyes et al, a native, triple 
helical peptide sequence of GFOGER of collagen type I was described as a 
key binding locus of 21 integrin, important in the downstream osteoblast 
phenotype [92]. Adhesion of cells to gelatin is mediated by other families of 
integrins such as v3 which are not involved in osteogenic differentiation 
signal transduction. 
 The presence of OIC (induced groups) generally increased the amount 
of COL1A1, ALP and OCN mRNAs seen at all time-points (Fig. 18B, C, D). 
Regardless of media composition, BMC cultured on PCL/Col exhibited higher 
expression of these genes compared to those grown on PCL/Gel. This fact 














Figure 18. Osteogenic gene expression analyses of BMC cultured on PCL, 
PCL/Col and PCL/Gel electrospun meshes. Upstream osteogenic 
transcription factor CBFA1 gene was significantly up-regulated in the PCL/Col 
group at all time-points (A). The PCL/Col induction group showed significantly 






and augmenting osteogenic differentiation of mesenchymal progenitor cells 
compared to gelatin-modified ones. COL1A1 gene expression was more 
pronounced during the earlier time-points in PCL/Col groups while ALP and 
OCN expressions were more marked at later time-points. Although collagen 
type I is generally expressed by mesenchymal cells undergoing transition 
towards the osteoblastic phenotype, its early deposition is crucial in creating 
the right environment for mineralization of bone [93]. ALP and OCN are 
middle to late markers of osteoblastic differentiation crucial in the control of 
bone mineralization [94].  
   In light of these findings, although exposure of collagen to HFIP may 
have caused structural deterioration, some degree of biological activity 
preservation transpired. This was seen when PCL electrospun meshes with 
surface collagen was compared with its completely denatured counterpart, 
gelatin, in terms of their ability to modulate mesenchymal to osteoblastic 
transition. The combination of superior bioactivity and mechanical strength of 




Materials and methods 
 
Materials and reagents. All reagents and chemicals were purchased from 
Sigma (St. Louis, MO) unless otherwise stated. All cell culture reagents and 
supplements were purchased from Gibco (Grand Island, NY). Medical grade 
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PCL was purchased from Absorbable Polymers International (Birmingham, 
AL). Medical grade type I bovine collagen was purchased from Symatese 
Biomateriaux (Chaponost, France). A high voltage generator was purchased 
from Gamma High Voltage Research (Ormond Beach, FL). Syringe pumps for 
electrospinning were purchased from kd Scientific (Holliston, MA). 
 
Fabrication of scaffolds. Electrospinning of PCL and PCL/Col 20% was 
described in the previous chapter. PCL/Gel 20% solution was prepared by a 
80:20 mass ratio of PCL to gelatin (i.e. similar to PCL/Col but substituting 
collagen with gelatin). Total solute concentration was kept the same at 12.5% 
w/v. Electrospinning of this solution was performed with a 10 kV voltage, 15 
cm distance and 0.75 mL/hr flow rate. A 21-G needle was used as a charged 
capillary to eject the material onto a flat aluminum collector. The non-woven 
PCL/Gel mesh was then stored in a dry cabinet. 
 
Scanning Electron Microscope (SEM). Dried fibrous meshes were cut into 1 
cm x 1 cm squares for SEM viewing. Samples were mounted on SEM stubs 
and sputter coated with Au using BALTEC glow discharge sputter coater 
(Liechtenstein). Viewing was done with a JEOL 5600 electron microscope 
system under 10 kV accelerating voltage. 
 
Immunofluorescence. Dried fibrous meshes were cut into 1 cm x 1 cm 
squares and were incubated with a mouse monoclonal antibody against 
porcine collagen type I at 4 oC for 16 hours. Following washing with 
phosphate-buffered saline (PBS), the samples were incubated with a FITC-
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labeled antibody against mouse IgG at ambient temperature for 30 minutes. 
Viewing was done using an Olympus FV500 laser scanning confocal 
microscope (LCSM) system. 
 
Tensile test. Tensile tests were done on the meshes previously cut into 3.5 
cm by 1 cm strips using an Instron tensile tester with 100 N load cell. All tests 
were done in PBS immersion at 37 oC with a crosshead speed of 10 mm/min 
until scaffold failure. Calculation for stress was performed using the nominal 
cross section area of the individual mesh samples.  
 
BMC culture. BMC were isolated from the iliac crest of Duroc-Yorkshire pigs 
weighing between 45-50 kg and aged 16-18 weeks. Briefly, a 20 mL syringe 
containing 1.5 mL of 5000 IU/mL heparin was used to extract 10-15 mL of 
bone marrow aspirate. The aspirate was then gently mixed and placed into 
tissue culture flasks. Approximately 3 mL of the aspirate was plated on a T150 
culture flask containing 25 mL expansion culture media (DMEM supplemented 
with 10% FBS and 1% antibiotics). The cells were then cultured in a heat 
sterilizable humidified incubator with 5% CO2 atmosphere (Binder GmbH, 
Tuttlingen, Germany) at 37 oC. Sub-culturing of cells was performed by 0.25% 
Trypsin enzymatic digestion once cells reached 70-80% confluency. Passage 
2-3 cells were used in these studies. 
 
Scaffold seeding and culture. BMC (20,000 cells/cm2) were seeded on 
electrospun meshes cut into 1.5 cm by 1.5 cm squares. The scaffolds were 
previously ethanol sterilized, UV irradiated for 15 minutes and conditioned 
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overnight in culture media. PCL, PCL/Col and PCL/Gel meshes were used in 
this study and each material is divided into two sub-groups: induced and un-
induced. A total of six study groups were present. Induced groups were 
cultured in media supplemented with osteogenic differentiation factors (10 nM 
dexamethasone, 50 M ascorbic acid 2-phosphate and 10 mM -
glycerophosphate) while un-induced groups were maintained in basal media. 
Experiments were conducted up to four weeks with pre-determined time-
points at 7, 14 and 28 days post-seeding. 
 
Cell proliferation assay and SEM of cell-scaffold constructs. At pre-determined 
time-points, cell-scaffold constructs were collected from all six study groups. 
Samples were then placed in a 24 multi-well plate and immersed in 500 L 
sterile distilled water. DNA extraction was performed via the freeze-thaw 
method consisting of three cycles of freezing in -80 oC followed by complete 
thawing to ambient temperature. Total DNA amount in the resulting 
suspensions was measured using PicoGreenTM dsDNA quantitation assay in 
accordance to the manufacturer’s protocol. Fluorescence measurements were 
done at 485 nm (excitation) and 535 nm (emission) using a TECAN 
spectrophotometer (Salzburg, Austria). For SEM of the constructs, one day 
post-seeding constructs were fixed in 2.5% glutaraldehyde overnight at 4 oC. 
This was followed by serial dehydration with ethanol and drying in a dry 
cabinet. SEM was performed after coating the samples with gold using a 





Real-time Reverse Transcription-Polymerase Chain Reaction (qPCR). At pre-
determined time-points, cell-scaffold constructs from all six groups were 
collected. RNA extraction was performed using Trizol lysis followed by 
purification using the QIAGEN RNeasy Mini Kit as per manufacturer’s protocol 
(QIAGEN, Valencia, CA). Reverse transcription was then performed on the 
total RNA to obtain cDNA by using the QIAGEN Quantitect RT Kit as per 
manufacturer’s protocol in a PCT-150 MinicyclerTM (MJ Research, Waltham, 
MA). Quantitative PCR was performed on the transcribed cDNA by using the 
QIAGEN Quantitect SYBR Green PCR Kit as per manufacturer’s protocol in a 
Stratagene MX1000P thermal cycler (Stratagene, La Jolla, CA). The 
expressions of five genes were investigated: CBFA1, COL1A1, ALP and OCN 
as osteogenic marker genes and GAPDH as a house-keeping gene. 
Specificity of amplifications was confirmed by performing melting curve 
analysis after each PCR reaction. The primer sequences for all five genes are 
given in Table 1 below. Data analyses were performed using the Pfaffl  
Table 1. Quantitative real time PCR was performed using primers specific for 
the amplification of osteogenic marker genes CBFA1, COL1A1, ALP and 
OCN. Amplifications of GAPDH genes were used to normalize cDNA input 
loading between samples. 
 
Gene ID Forward primer Reverse primer 
GAPDH GCTTTGCCCCGCGATCTAATGTTC GCCAAATCCGTTCACTCCGACCTT 
CBFA1 GAGGAACCGTTTCAGCTTACTG CGTTAACCAATGGCA CGA G 
COL1A1 CCAAGAGGAGGGCCAAGAAGAAGG GGGGCAGACGGGGCAGCACTC 
ALP ATGAGCTCAACCGGA ACA A GTGCCCATGGTC AATCCT 
OCN TCAACCCCGACT GCGACGAG TTGGAGCAGCTG GGATGATGG 
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method of real time PCR data comparisons taking into account primer 
efficiency values. Standard deviations were obtained from Ct values of three 
different samples per study group. 
 
Statistical analysis. Statistical analysis of data was performed by using a two-


































Design and characterization of the fibrous layer 
 
Although tissue engineered constructs must be tailored specifically to the 
unique site of injury, certain intrinsic properties are expected from a scaffold. 
The scaffold’s biochemical properties and architecture should support cellular 
attachment, migration, growth and ultimate tissue maturation [7]. An open and 
interconnected pore system within the three-dimensional (3D) structure is 
critical in ensuring proper nutrient and waste transport, tissue in-growth, 
vascularization and eventually integration of the constructs with the host. As 
shown in the previous sections, electrospinning provides a simple and user-
friendly method of fabricating micro to nano scaled fibers that are within the 
size range of the ECM [129]. Their unique properties and topographical 
features, along with the versatility of electrospinning technique, make 
electrospun fibers an interesting candidate as tissue engineering scaffolds 
[130-132].  
 The challenge comes however, from the difficulty in creating good 
integration between the electrospun scaffolds with cells and ECM. More often 
than not, cells cultured on electrospun fibers remain largely on the surface i.e. 
lacking structural penetration as previously reported [51, 74, 75, 133-135]. 
This issue with cellular infiltration into the fiber architecture is rapidly gaining 
attention due to its potential in stagnating further applications of electrospun 
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meshes or scaffolds. The conventional technique of electrospinning onto a 
static, flat collection screen provides a simple and inexpensive way of 
obtaining nanofibers. Meshes collected in this manner however, will have 
tremendous fiber density built over time. Also, it has been reported that by 
decreasing the electrospun fiber diameter, an increase in the number of fiber-
to-fiber contacts per unit length and a corresponding decrease in the mean 
pore radius in the mesh are expected [136]. These factors create a large size 
mismatch between the small pores in the structure and the larger physical 
size of the cells, limiting the ability of the cells to migrate and populate the 
scaffold’s interior. It is therefore of great importance to formulate a method 





This chapter focuses on the investigations of a technique that will allow the 
fabrication of cell permeable electrospun structures. The feasibility of three 
methods based on the co-electrospinning technique was examined to achieve 
this goal. The first method involving selective leaching of a water soluble fiber 
phase was established by co-electrospinning PCL/Col fibers with gelatin or 
poly (ethylene oxide)(PEO) fibers. The second method involved the 
fabrication of PCL/Col electrospun meshes with larger diameter fibers i.e. 
micro-fibers of PCL/Col (PCL/Col). The third method was the exploitation of 
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a simultaneous electrospinning and electrospraying of PCL/Col fibers and a 
hyaluronic acid (HA) based hydrogel, respectively. 
 
 
Figure 19. Modifications to the conventional electrospinning setup (A) were 
performed to allow different materials to be electrospun (B) or electrosprayed 
(C) together with PCL/Col. PCL/Col-Gel and PCL/Col-PEO were fabricated 
using simultaneous co-electrospinning on a rotating mandrel. Gelatin and 
PEO were then selectively leached out in aqueous solution. HeprasilTM, a 
hyaluronic acid derivative hydrogel, was electrosprayed into the structure of 
PCL/Col mesh as the fibers were deposited on a rotating mandrel. 
 
 To enable the fabrication of said scaffolds, modifications of the 
conventional electrospinning setup (Fig. 19A) were performed. These 
included the replacement of the collection plate with a rotating mandrel and 
the addition of another electrospinning tip for PEO, gelatin or HeprasilTM. For 
the simultaneous co-electrospinning of two fiber species, PCL/Col was 
electrospun from one charged needle while PEO or gelatin was electrospun 
from another charged needle onto the opposite side of the mandrel with 
inverse polarity (Fig. 19B). In the case of co-deposition of PCL/Col with 
HeprasilTM, HeprasilTM was loaded into the other charged needle for 
electrospraying purposes. In this manner, jets of charged hyaluronic acid 
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hydrogel droplets were ejected from the tip onto the rotating mandrel where 
PCL/Col fibers were being deposited (Fig. 19C). Opposing electric polarities 
were used to overcome charge repulsion issues which may impair uniform 
and proper mixing of the fibers or fiber/droplets. It has been reported  
 
 
Figure 20. Morphology of the resulting electrospun fibers were studied via 
electron microscopy. Conventional electrospun PCL/Col fibers showed 
diameters in the sub-micron range (A). Co-electrospinning two fiber materials 
yielded meshes with two different fiber groups, noticeable by their differences 
in size (B – PCL/Col-PEO, C – PCL/Col-Gel). A micron-sized PCL/Col 
(PCL/Col) mesh was fabricated by means of increased solution 
concentration (D, E). Electrosprayed HeprasilTM in the PCL/Col-Hep 
structure could not be observed under SEM due to the dehydration process 
during specimen preparations (E). A graph comparing the difference in fiber 
diameters obtained by the different methods is shown in F. Bar represents 5 
m in A, B; 20 m in C-E.  
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elsewhere that when similar polarities were used for co-electrospinning, a 
mandrel with transverse movement was required to ensure uniform fiber 
distribution [137]. 
 Electron micrographs of the as-spun fibers obtained by the three 
methods are shown in Figure 20. All fibers appeared similar and uniform albeit 
the differences in diameters. Conventionally electrospun PCL/Col (Fig. 20A) 
had diameter distributions of 513 ± 83 nm. When co-electrospun together with 
PEO (Fig. 20B) and gelatin (Fig. 20C), the average PCL/Col fiber diameter 
became 611 ± 158 nm and 724 ± 149 nm, respectively. Furthermore, a 
second larger fiber group was observed in the co-electrospun meshes and 
identified as the PEO fibers (in PCL/Col-PEO) and gelatin fibers (in PCL/Col-
Gel). Micron-sized PCL/Col (PCL/Col) was fabricated using a higher 
concentration solution for electrospinning and resulted in fibers in the 
diameter range of 1.29 ± 0.11 m (Fig. 20D). Electrospraying HeprasilTM with 
the PCL/Col resulted in larger diameter fibers of 1.61 ± 0.27 m (Fig. 20E). A 
graph comparing the resulting fiber diameters from all the electrospun fiber 
groups is shown in Figure 20F. The inter-fiber distances and pore sizes 
appeared larger in PCL/Col and PCL/Col-Hep meshes compared to 
PCL/Col, PCL/Col-Gel and PCL/Col-PEO. The embedded hydrogel was not 
clearly visible under SEM due to an expected collapse of the hydrogel 
structure during the processing which involved stringent dehydration steps. 
 Both the simultaneous co-electrospinning and electrospinning-
electrospraying processes were successful in fabricating meshes with mixed 
fibers species and embedded HeprasilTM hydrogel, respectively. PEO fibers 




Figure 21. Fiber visualization was performed by incorporating fluorescent dye 
during the electrospinning process. Co-electrospinning results were visualized 
by doping the PCL/Col solution with rhodamine (A) and PEO with FITC (B). 
This process yielded an electrospun mesh with mixed PCL/Col and PEO 
fibers in its structure (C). Subsequent leaching of PEO from the mesh left the 
PCL/Col fibers intact (D). Analysis of the embedded HeprasilTM was 
performed by incorporating AlexaFluor-labelled Bovine Serum Albumin (AF-
BSA) into the hydrogel mix followed by confocal microscopy of the transverse 
(E) and planar sections (F). Efficiency of HeprasilTM incorporation into the 
PCL/Col mesh during the electrospinning process was investigated by 
enzymatically digesting the hydrogel and measuring the released AF-BSA. A 
graph of efficiency as a function of collection mandrel diameter is shown in G. 




differences. Gelatin fibers were only slightly larger than PCL/Col fibers. By 
increasing the electrospinning solution concentration from 12.5% w/v (as was 
used in conventional PCL/Col) to 20% w/v, larger PCL/Col fibers were formed. 
The increment in polymer solution content resulted in an increase in the 
solution’s viscosity. A higher viscosity reduced the bending instability 
phenomenon which in turn resulted in larger diameter fibers[138]. As reported 
previously, an increase in fiber diameter also increased the apparent inter-
fiber distances and pore size [139]. 
 Visualization of fibers and fiber-hydrogel mixing was performed via 
addition of fluorescent dyes followed by confocal laser microscopy (Fig. 21).  
Rhodamine-doped PCL/Col (Fig. 21A) and FITC-doped PEO (Fig. 21B) 
showed relatively uniform and continuous formation of fibers. Co-deposition of 
these two fibers into a PCL/Col-PEO mesh revealed good intermixing of the 
fibers in the structure (Fig. 21C). PEO was easily removed by water 
immersion leaving intact PCL/Col in the mesh (Fig. 21D). The AlexaFluor488-
BSA loaded HeprasilTM formed HA rich regions in the PCL/Col fibrous 
architecture after the electrospinning-electrospraying process (Fig. 21E, F). 
The electrospraying process produced random dispersion of the regions 
throughout the structure. Due to the randomness of the process, coalescence 
of the hydrogel during deposition could have caused larger sized regions to 
form resulting in a large distribution of size ranging from a few tens of microns 
to several hundred microns.  
 The efficiency of the hydrogel incorporation with respect to the 
collection mandrel size was investigated by fabricating the mesh using three 
different diameters of mandrel. Figure 21G shows the percentage efficiency 
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when 0.8, 1.4 and 1.7 cm diameter mandrels were used as collection 
platforms. A marginal increment in efficiency was observed when mandrel 
size was increased from 0.8 to 1.4 cm. However, a more pronounced increase 
was observed when mandrel diameter was further increased from 1.4 to 1.7 
cm which implies a reduction in material loss from 70% down to about 25%. 
Given the same capillary-to-collection distance, a larger mandrel would be 
able to capture the ejected hydrogel droplets more efficiently than a smaller 
one. The issue of material loss becomes increasingly critical when costly 
bioactive molecules such as growth factors are incorporated into the mesh via 
the hydrogel. Meshes produced using the largest mandrel were used for 
subsequent cellular attachment and infiltration experiments. 
 
 
Cell permeable electrospun scaffolds 
 
To assess cellular attachment, material toxicity and extent of cellular 
infiltration into the fibrous meshes, human fetal osteoblasts (hFOBs) were 
seeded on the scaffolds. Scanning electron microscope analysis of the 
meshes after three and ten days of in vitro culture is shown in Figure 22. Cells 
were observed to be morphologically flatter and more spread when cultured 
on conventional PCL/Col, PCL/Col-Gel and PCL/Col-PEO. Cells were also 
observed to possess adhesion points to multiple fibers on these meshes. 
They remained predominantly on the surface as monolayer-sheets with 
filopodia bridging the fibers instead of extending into the pores. Cellular 
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infiltration was not observed on the PCL/Col and PCL/Col-Gel meshes while 
sporadic sub-surface migration of cells down to several layers of fibers was 
observed on the PCL/Col-PEO mesh. In contrast, cells on the PCL/Col and 
PCL/Col-Hep meshes were more rounded and spindle-shaped with adhesion 
to fewer fibers due to the larger fiber sizes. At later time-points, cells could be 
found in the interior of the PCL/Col and PCL/Col-Hep scaffolds. This 
suggested that the alterations in the architecture resulted in pore sizes that 
allowed vertical cellular migration from the surface to the interior of the 
scaffolds. These cells exhibited a more 3D morphology with adherence to 
multiple fibers in the interior. 
 To assess the possibility of cytotoxicity due to the materials and 
electrospinning process, a qualitative live/dead cell assay was performed (Fig. 
23). Cells remain largely viable after three and ten days of in vitro culture in all 
scaffold groups (viable cells were stained green while the nuclei of dead cells 
were stained red) and cellular proliferation was observed as well on all 
scaffolds. No apparent toxicity was observed from the inclusion of gelatin, 
PEO or HeprasilTM hydrogel in the scaffold design. Furthermore, no toxicity 
was seen from the electrospinning solvent used. As implantable biomaterials, 
minimum toxicity is desired to avoid immune rejection and fibrosis at the 
implantation site. 
 Infiltration of cells into the scaffolds architecture was studied by 
transverse sectioning of the meshes followed by histological staining 
(Hematoxylin & Eosin) to reveal cell localization (Fig. 24). A monolayer of cells 
was found to be situated exclusively on the surface of conventionally 




Figure 22. Cellular attachment and morphology on the five electrospun fiber 
groups were analyzed via scanning electron microscopy at three and ten days 
of in vitro culture. When cultured on conventional PCL/Col and PCL/Col gel 
nanofiber meshes, the cells remained exclusively on the mesh’s surface. Sub-
surface localization of cells was observed in the PCL/Col-PEO mesh. Cellular 
infiltration was apparent in the PCL/Col and PCL/Col-Hep meshes. Bar 
represents 10 m in all images. 
 
creating a less dense PCL/Col mesh post leaching compared to the smaller 
gelatin fibers in PCL/Col-Gel. However, the fast leaching of the water soluble 
fibers resulted in a collapse of the meshes’ structure. We conclude that this 




Figure 23. Viability of hFOBs on the electrospun meshes were studied 
qualitatively using a live/dead cell assay at three and ten days of in vitro 
culture. No apparent toxicity was observed when gelatin, PEO and HeprasilTM 
were used. Their viability was comparable to conventional PCL/Col and 
PCL/Col groups. Bar represents 200 m in all images. 
 
Although quantitative comparison was not performed on the mesh 
thicknesses before and after leaching of the sacrificial polymers PEO and 
gelatin, qualitative observation did reveal a more significant reduction in 
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thickness of the PCL/Col-PEO mesh compared to the PCL/Col-Gel mesh. An 
explanation for this is the difference in size between PEO and gelatin fibers. 
The collapse of the larger PEO fibers resulted in a higher thickness reduction 
of the mesh compared to the smaller gelatin fibers. 
 Creating meshes with micron-sized fibers in PCL/Col resulted in a 
less dense fibrous structure. More cells were able to migrate vertically into the 
mesh’s architecture as corroborated by SEM observations. Co-deposition of 
HeprasilTM hydrogel with the PCL/Col considerably improved cellular 
infiltration. Cells were able to penetrate the full thickness of the PCL/Col-Hep 
mesh. The inclusion of HeprasilTM globules into the PCL/Col mesh created a 
reduction in volume density of fibers and created compartments of 
biodegradable glycosaminoglycan hydrogel that allowed passage of infiltrating 
cells. In order to compare the infiltration extent between the scaffold groups, a 
grid system was devised to quantitatively analyze the cell penetration depth. 
An array of vertical columns was overlaid on histological pictures (Fig. 25A) 
and cell depth from the surface was measured and compared between groups 
(Fig. 25B). From the results, incorporation of HeprasilTM globules in the 
PCL/Col fibrous structure significantly improved cellular infiltration into the 
scaffold mesh. 
 Previous reports have been published on the attempts to create cell 
penetrable electrospun scaffolds. Kidoaki et al proposed the concept of 
selective polymer leaching to create microvoids using a water soluble polymer 
such as PEO for an intermixed structural fiber species [137]. This hypothesis 
was tested as described above by co-electrospinning PCL/Col fibers with 
PEO or gelatin. However, this method only offered marginal improvements in 
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terms of cell infiltration. Simple blending of gelatin in PCL electrospinning 
solution was reported to improve cellular infiltration due to the rapid 
dissolution of gelatin [80]. However, this claim was not substantiated with data 
confirming the distribution of cells across the mesh’s thickness. Nam et al 
utilized a salt leaching method whereby NaCl particles were mechanically 
dispersed in a polymer solution followed by electrospinning [140]. Although 
large pores were created this way, very dense fiber sheaths were still present 
in between the created macropores. Cellular infiltration was only possible 
through surface migration and continuous proliferation into the delaminations 
or voids, and not through the fiber architecture. Pham et al reported good 
infiltration of cells when electrospun fibers of 5-10 m were used in 
conjunction with dynamic flow perfusion cell culture technique [139]. The 
usage of much larger fibers however, would divert away from creating a more 
ECM-mimetic environment through electrospinning. Furthermore, they 
observed significant reduction in cellular infiltration when more conventional 
nanofibers were intermixed in the mesh even with dynamic culturing. 
 The hybrid mesh fabricated using the above mentioned modified 
electrospinning-electrospraying setup allowed superior cellular infiltration over 
conventionally electrospun meshes. Increasing the fibers’ size to 1-2 m in 
combination with the presence of a biodegradable hyaluronic acid hydrogel 
throughout the architecture provided the cells with a sufficiently large pore 
system and interconnectivity for vertical migration. HeprasilTM is a synthetic 
ECM based on chemically-modified HA and chemically-modified heparin [141] 
developed for cell culture and tissue engineering [142]. HA has shown 




Figure 24. Cellular infiltration into the electrospun fiber meshes’ structure were 
investigated via histological staining (Hematoxylin & Eosin). Cellular infiltration 
was not observed in conventional PCL/Col and PCL/Col-gel groups. Marginal 
infiltration was seen in the PCL/Col-PEO group after ten days with a majority 
of cells still forming cell sheets on the surface. Obvious cellular infiltration was 
perceived in the PCL/Col group and was even more pronounced in 
PCL/Col-Hep. After ten days of culture, cells were able to penetrate 
approximately half of the thickness of PCL/Col and throughout the structure 
of PCL/Col-Hep. Arrow heads indicate the stained cell nuclei. Bar represents 




Figure 25. Qualitative comparison of the extent of cellular infiltration into the 
scaffolds’ architecture was performed by overlaying a grid system on 
histological sections and measuring cell infiltration depth (A). When all the five 
groups were compared, PCL/Col-Hep showed the greatest infiltration depth 
after three and ten days of in vitro culture (B). Bar in A represents 50 m. 
 
preservation of cellular phenotype and controlled release of bioactive 
molecules [143-145]. Inclusion of this HA hydrogel provided the cells with 
pockets of enzymatically degradable matrix within the PCL/Col fiber 
assembly into which cells could migrate. Moreover, the co-deposition of 
HeprasilTM in a tissue engineering scaffold opens the possibility of bioactive 
factor loading. As previously reported, the HA hydrogel alone could be utilized 
as a controlled release vehicle for growth factors such as vascular endothelial 
growth factor (VEGF) and fibroblast growth factor (FGF) due to the presence 
of cross-linked heparin in its structure [141, 146, 147]. 
 Based on the results and analyses described above, electrospun 
PCL/Col-Hep demonstrated excellent potential to be exploited as truly 3D 
tissue engineering scaffolding. This scaffold design and composition is 
investigated further in the next chapter as the fibrous compartment in our 
periosteal scaffold model. 
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Materials and methods 
 
Materials. All reagents and chemicals were purchased from Sigma (St. Louis, 
MO) unless otherwise stated. Cell culture reagents and supplements were all 
obtained from Gibco (Grand Island, NY) unless otherwise stated. Medical 
grade PCL was purchased from Absorbable Polymers International 
(Birmingham, AL). Medical grade type I bovine collagen was purchased from 
Symatese Biomateriaux (Chaponost, France). HeprasilTM was obtained as a 
kind gift from Glycosan Biosystems (Salt Lake City, UT). A high voltage 
generator was purchased from Gamma High Voltage Research (Ormond 
Beach, FL). Syringe pumps for electrospinning were purchased from kd 
Scientific (Holliston, MA).  
 
Fabrication of scaffolds. The electrospinning solution was made by preparing 
a 20% w/v solution of PCL/Col (80/20 by mass) in 1,1,1,3,3,3-fluoro 2-
propanol (HFIP). This solution was then electrospun using a 19-G blunt 
needle connected to a negative 9 kV power supply. Material feed rate and 
needle-to-mandrel distance of 4.0 mL/hr and 6 cm was used, respectively. 
This process yielded PCL/Col fibers with diameter of one to two micrometers 
(PCL/Col). HeprasilTM was prepared as per manufacturer’s protocol.  Briefly, 
lyophilized HeprasilTM and its thiol-reactive crosslinking agent, ExtralinkTM 
were reconstituted into their recommended working concentrations and mixed 
together to form the hydrogel solution with a 4:1 volume ratio of HeprasilTM to 
ExtralinkTM. For electrospraying, the solution was further mixed in 1:1 volume 
ratio with 3% gelatin solution to modify its viscosity and gelling time. The 
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hydrogel solution was electrosprayed within 30 minutes after mixing of the 
components, before extensive crosslinking occurred. Electrospraying was 
undertaken by connecting a 21-G blunt needle to a positive 7 kV power supply 
with a hydrogel solution feed rate of 1.6 mL/hr and distance of 6 cm. The 
PCL/Col-Hep scaffolds were made by simultaneous collection of electrospun 
PCL/Col and electrosprayed HeprasilTM solution on a grounded collection 
mandrel rotating at 100 revolutions per minute (RPM) speed. The collected 
mesh was stored in a dessicator overnight to allow complete evaporation of 
the organic solvent.  
 Conventionally electrospun meshes were made by preparing 12.5% 
w/v solution of PCL/Col (80/20 by mass) in HFIP. This solution was then 
electrospun onto an earthed flat metal collector with positive 10 kV voltage at 
0.75 mL/hr feed rate at a 10 cm tip-to-collector distance. Selectively leached 
PCL/Col scaffolds were made by co-electrospinning 12.5% w/v PCL/Col 
solution with either 20% w/v poly(ethylene oxide) for PCL/Col-PEO or 10% 
w/v gelatin for PCL/Col-Gel in HFIP using a rotating mandrel connected to 
ground (100 RPM) for collection. The electrospinning voltage used was 
negative 9 kV for PCL/Col and positive 7 kV for both PEO and gelatin. Tip-to-
collector distance was kept at 6 cm for both capillaries while material feed rate 
was 0.75 mL/hr for PCL/Col and 1.25 mL/hr for both PEO and gelatin. The 
collected meshes were kept in a dessicator overnight to allow complete 
evaporation of organic solvent. PEO was removed from the PCL/Col-PEO 
scaffolds by water immersion for one hour at room temperature with 
continuous agitation. Gelatin was left in the PCL/Col-Gel structure until cell 




Scaffold characterization and cell culture. Morphology of the fibrous meshes 
was examined by gold coating a small sample of the mesh previously cut into 
1 cm x 1 cm specimens using a glow discharge sputter-coater (BALTEC, 
Liechtenstein) followed by viewing under a JEOL 5600 electron microscope 
(JEOL, Japan) with 10 kV accelerating voltage. Fiber diameter measurements 
were performed on the electron micrographs using ImageJ, an open source 
image analysis software from the National Institutes of Health (NIH). The co-
electrospinning processes were confirmed by incorporating 0.05% w/v 
rhodamine dye into the PCL/Col solution and 0.05% w/v fluorescein 
isothiocyanate (FITC) dye into the PEO solution. The co-deposited meshes 
were cut into 1 cm x 1 cm pieces followed by viewing under the laser 
scanning confocal microscope (Olympus, Tokyo, Japan). Regions of 
HeprasilTM embedded in the scaffolds were viewed by incorporating 
AlexaFluorTM 488-labelled bovine serum albumin (AF-BSA; Invitrogen, 
Carlsbad, CA) dye into the hydrogel during electrospraying and viewing under 
the laser scanning confocal microscope. Loading concentrations were set at 
0.75 g per cm2 of mesh produced. The effect of the mandrel diameter used 
as a collection platform to the efficiency of hydrogel incorporation into the 
electrospun mesh via electrospinning was studied by fabricating three 
different meshes using mandrels of 0.8, 1.4 and 1.7 cm in diameter. All three 
meshes had AF-BSA incorporated into the hydrogel. Other electrospinning 
parameters were kept constant. The three meshes were cut into 1 cm x 1 cm 
pieces and were incubated in a 3% bovine testes hyaluronidase solution in 37 
oC for 24 hours to digest the hydrogel. The supernatant solutions were 
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sampled at the end of the digestion period and fluorescent intensities at 520 
nm were read via a FLUOstar Optima spectrophotometer (BMG Labtech, 
Offenburg, Germany). Incorporation efficiency was calculated by dividing the 
spectrophotometer readings by the pre-electrospraying loading and 
multiplying by 100%. Five samples from each mandrel size were processed 
and a triplicate reading from each sample was taken. 
 Human fetal osteoblasts (hFOBS; ATCC, Manassas, VA) were used as 
the model cell line for cellular attachment and infiltration assays. The cells 
were culture expanded in Dulbecco’s Modified Eagle Media (DMEM) 
supplemented with 10% fetal calf serum and 1% antibiotics in a humidified, 
5% CO2 incubator at 37 oC. For cell seeding, the meshes were cut into discs 
of 8 mm in diameter using a biopsy punch (B.Braun Medical, Bethlehem, PA). 
Prior to cell seeding, meshes were sterilized via ethanol immersion and UV 
irradiation. Each mesh was then placed in a 100 m cell strainer (BD, Franklin 
Lakes, NJ) in 60 mm Petri dishes (TPP; Trasadingen, Switzerland). Media 
conditioning was done on all the meshes by pipetting 15 mL of cell culture 
media into each Petri dish and incubating them overnight in a humidified, 5% 
CO2 incubator at 37 oC. HFOBs were trypsinized, counted and seeded onto 
each disc with a density of 50,000 cells per disc. The cell-scaffold constructs 
were then cultured for a maximum of ten days in working hFOBs media. On 
the third and tenth day after seeding, constructs were analyzed for cellular 
viability, morphology and infiltration into the structure.  
 Morphology and attachment of cells on the scaffolds was imaged using 
a scanning electron microscope (SEM). At the pre-determined time-points of 
three and ten days, constructs were collected and fixed in 2.5% 
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glutaraldehyde overnight at 4 oC. The samples were then dehydrated by 
ethanol gradient methods followed by drying. For electron microscopy, the 
dried constructs were mounted on viewing stubs and gold sputtered using a 
glow discharge sputter coater. Viewing was performed under 10 kV 
accelerating voltage in a JEOL 5600 electron microscope. Viability of the cells 
was qualitatively assayed using a live-dead assay; fluorescein diacetate-
propidium iodide (FDA/PI) staining. At the pre-determined time-points, 
constructs were collected and incubated in 2 g/mL FDA solution for 15 
minutes in a humidified 5% CO2 incubator at 37 oC. Following stringent 
washings with buffered saline, the samples were then incubated in 50 g/mL 
PI solution for 2 minutes at room temperature. FDA/PI staining was imaged 
using an Olympus FV500 laser scanning confocal microscope.  
 For the cellular infiltration assay, the constructs were collected at the 
pre-determined time-points and were snap-frozen in a liquid N2 bath. The 
samples were embedded in cryo-freezing medium (Leica, Wetzlar, Germany), 
cut into 10 m sections using a Leica cryo-microtome and were fixed onto 
poly L-lysine coated microscope slides. The sections were then fixed in 10% 
formalin for 30 minutes at room temperature. Visualization of cells in the 
fibrous mesh was done by staining the fixed sections with hematoxylin and 
eosin (H & E). Cell nuclei stain bluish-purple while cytoplasm and ECM stain 
pink. Quantification of the extent of cellular infiltration was performed by using 
a modified method previously described by Pham et al[139]. For this purpose, 
a set of ten columns of 10 m width and 20 m apart from each other were 
overlaid on the H & E histology images. The deepest distance (relative to the 
mesh’s surface) was measured and recorded in each of the columns. Two 
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samples per group per time-point and at least three sections per sample were 
analyzed to obtain the quantitative infiltration depth data. Point-to-point 
distance measurements were performed using ImageJ.  
 
Statistical analysis. Statistical analysis of data was performed by using a two-






















Angiogenesis and tissue engineering scaffolds 
 
A major barrier in the development of functional tissue engineering scaffolds 
is the vascularization of the constructs. A vascular system is critical in 
ensuring proper nutrient and oxygen transport while allowing clearance of 
metabolic waste in a timely manner. Despite the success reported in tissues 
consisting of thin layers of cells such as bioengineered skin, tissue 
engineering large and more complex organs such as bone, kidney and the 
heart is met with more significant vascularization challenges. In these 
organs/tissues where a large collection of cells are present, a more complex 
and intricate network of arteries, veins and capillaries are needed [148]. Thus, 
to further improve the performance of tissue engineering constructs and their 
functional outcome, vascularization issues must be resolved. 
 Neo-vascularization can be classified into two sub-processes: 
angiogenesis and vasculogenesis. While vasculogenesis is the process of 
capillary formation by the in situ assembly of angioblasts, angiogenesis 
involves the formation of new capillaries from pre-existing ones. Although it 
was thought that angiogenesis and vasculogenesis were two independent 
processes, it is commonly accepted that both mechanisms are responsible for 
the formation of new blood vessels [149, 150]. New vessel formation is 
initiated by the binding of angiogenic stimuli such as vascular endothelial 
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growth factor (VEGF) and fibroblast growth factor (FGF) to the surface 
receptors on endothelial cells (EC). This in turn activates a plethora of 
signaling downstream resulting in expression of matrix metalloproteinases 
(MMPs) which aid EC migration from existing capillaries and cellular 
proliferation to form primary EC tubules [151, 152]. TGF-β, PDGF and other 
cytokines signaling recruit pericytes required for the maturation of these 
tubules [153, 154]. These pericytes protect and stabilize the newly formed 
vessels and prevent regression [154]. Neo-vascularization is essential in the 
maintenance of physiological functions and the wound healing process.  
 In the setting of a bioengineered tissue constructs, although new 
vessels are often seen forming near and in the implanted sites, 
vascularization is often too slow and too limited to provide transport of 
nutrients and oxygen to the transplanted cells [155]. Metabolically inactive or 
even necrotic tissues frequently occurs due to insufficient nutrient and/or 
oxygen supply in large constructs without a proper transport system [156]. 
Thus, proper neo-vascularization must be taken into consideration in the 
design and fabrication of three dimensional (3D) bioengineered tissue 
constructs. Approaches to tackle this issue include the seeding of EC into 
scaffold matrices [157-159], in vitro pre-vascularization of constructs[160] and 
incorporation of angiogenic growth factors (GFs) into tissue engineering 
scaffolds [108, 161]. Each of these approaches has its own advantages and 
limitations.  
 Seeding of EC with or without other cell types have been reported to 
aid the formation of new capillaries in implanted scaffolds. The vessels formed 
were observed to be stable and similar to natural vessels [158]. Issues raised 
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against the usage of EC transplantation into a scaffold include problems of 
cell source and the possibility of immune rejection. However, isolation and use 
of Endothelial Progenitor Cells (EPCs) from the patient’s own blood is 
currently seen as a way of circumventing these obstacles [162]. Another 
approach is the formation of blood vessels in the bioengineered tissue prior to 
implantation i.e. pre-vascularization. Reports were published whereby 
vascular frameworks were created via fibro-vascular tissue infiltration in vivo 
[160] or ex vivo [163] and micro-channel patterning on polymers [164]. The 
method of pre-vascularization again becomes critical (cells/animal host) when 
the scaffold is to be used in a human clinical setting.  The necessity to pre-
vascularize a construct is often questioned since implanted bio-scaffolds are 
inevitably remodeled in vivo. Furthermore, anastomosis failure with the host 
vasculature will render the pre-vascularization obsolete and lead to graft 
deterioration. Pro-angiogenic therapy using vascularization-promoting GFs 
has been widely used clinically [165]. However, issues with delivery, dosage, 
stability and types of GFs to use, complicate the application in tissue 
engineering [166]. A plausible solution is the design and fabrication of three-
dimensional tissue engineering scaffolds with the capability for controlled 







In vitro co-culture of EC and fibroblast 
 
Significant contributions have been reported in the assay of angiogenesis 
using conventional in vitro model systems such as collagen gels and 
Matrigels. However, co-culture systems of EC with other cells e.g. smooth 
muscle cells and fibroblast are considered to be more appropriate. Gel type 
EC culture systems are grossly under-estimating the association and 
involvement of other matrix cells. Albeit more complex, co-culture systems 
would provide a more relevant and better approximation of the 3D micro-
environment needed by the EC to exhibit their native phenotype [169]. As 
fibroblast activation and migration is observed in processes that involve 
angiogenesis such as wound healing, their use as mural cells in an EC co-
culture system is justified. 
 In order to investigate the prospective application of the developed 
PCL/Col-Hep electrospun mesh as a periosteum graft, a stable and reliable 
EC-fibroblast co-culture system must be established. Human umbilical vein 
endothelial cells (HUVEC) and IMR90 human lung fibroblast cell lines were 
pre-assessed for a 3D scaffold application in a 2D co-culture system. The in 
vitro culture of these cells, individual and as a co-culture system is shown in 
Figure 26. HUVEC exhibited typical endothelial morphology under phase 
contrast microscopy, showing cell cluster formations prior to confluence, with 
cobblestone morphology. IMR90 fibroblasts on the other hand, were observed 
to be spindle-shaped throughout. The cultured HUVEC were found to express 
the ubiquitous von Willebrand Factor (vWF) protein strongly while no signal 
was detected from the fibroblast monolayer. Thus, vWF was used to 
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distinguish and track the localization of HUVEC in the culture in downstream 
experiments. Co-culturing the two cell populations for 10 days resulted in 
extensive formation of endothelial tubules or commonly referred to as 
capillary-like structures (CLS). These elongated structures and networking of 
EC in the fibroblast matrix were clearly seen via vWF immunofluorescence 
staining (Fig. 26). They were not clearly discernable under phase contrast or 
Hoffman modulation contrast microscopy, indicating non-superficial 
localization of these structures. 
 
 
Figure 26. A co-culture of HUVEC and IMR90 was performed to determine 
their suitability as an in vitro angiogenesis assay of the electrospun meshes. 
Cultured HUVEC were stained positive for von Willebrand Factor (vWF) while 
IMR90 fibroblast cells did not. When co-cultured together, HUVEC 
spontaneously formed capillary-like structures (CLS) in vitro. Bar represents 
200 m in all images. 
 
 A co-culture system relies on the secretion of extracellular matrix 
components and growth factors by mural cells, which are critical for the 
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survival and function of EC [170]. The creation of an appropriate cellular 
micro-environment with appropriate signaling cues allowed the EC to assume 
their native phenotype. This 2D formation of EC CLS was similar to that 
reported by Bishop et al, whereby endothelial tubules formed within an 
environment of fibroblast and their matrix [171]. EC cultured alone under the 
same conditions did not form tubules [171]. Furthermore, EC tubules formed 
in a co-culture system with fibroblast resembled a physiological capillary bed 
more so than those obtained through the conventional Matrigel system [172]. 
Although HUVEC are not usually involved in the process of neo-
vascularization, they can display a latent angiogenic phenotype given the 
appropriate signals [173]. 
 Having established the HUVEC-fibroblast in vitro 2D co-culture model, 
this system was utilized to assess the ability of PCL/Col-Hep to support the 
attachment, growth and function of EC in a 3D setting. As previously 
described in the preceding chapter, PCL/Col-Hep was fabricated using a 
novel electrospinning-electrospraying system whereby micron-sized PCL and 
collagen blend structural fibers were deposited concurrently with droplets of 
hyaluronic acid (HA) hydrogels (Fig. 27). Due to its increased fiber 
dimensions, pore sizes were increased (Fig. 27A). Surface localization of 
collagen was still observed in these microfibers (Fig. 27B) as seen in 
conventionally electrospun PCL/Col described earlier. Collagen-rich domains 
were observed along the fibers’ surface under higher magnification of the 
immunofluorescence staining (Fig. 27C). Fluorescent labeling of the 
electrosprayed HA showed relatively uniform spatial and size distribution of 




Figure 27. A PCL/Col-Hep electrospun mesh was obtained by simultaneous 
electrospinning of PCL/Col fibers and electrospraying of HeprasilTM hydrogel 
(A). Collagen was localized on the surface of these fibers as shown by 
immunofluorescence staining (B). A higher resolution image of an area in B is 
shown in C. Collagen existed as patches or domains on the PCL/Col fibers. 
Cross-sectional and planar fluorescence microscopy was performed to 
observe the distribution of HeprasilTM in the mesh (D and E respectively). Bar 
represents 10 m in A; 200 m in B, D and E; 10 m in C. 
 
 The attachment and morphology of EC and fibroblast on the 
electrospun PCL/Col-Hep meshes were studied by seeding HUVEC and 
IMR90 onto their surfaces. Actin cytoskeletal staining and SEM images of 
HUVEC and IMR90 fibroblast cultured independent of each other are shown 
in Figure 28. Images from TCPS culture of the cells are also shown for 
comparison. Both EC and fibroblast cultured on electrospun meshes showed 
a more rounded and elongated morphology. This was in contrast to 2D culture 
on TCPS whereby a flatter and more spread morphology was dominant. This 
difference was more obvious with the EC; HUVEC cultured on PCL/Col-Hep 
appeared smaller and exhibited more directional cellular extensions. Actin 
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filaments were more prominent in cells cultured on 2D TCPS compared to the 
more 3D electrospun mesh as previously reported [174]. Such morphological 
changes are often reported when cells such as fibroblast and epithelials were 
cultured on 3D matrices reflecting a more physiological cellular state [175, 
176]. Nano- and micro-scaled topography has been reported to critically 
influence cellular functions and modulate their behavior [177]. Collagen 
coating of the fibrous mesh may have facilitated the adsorption of proteins 
such as fibronectins critical for 3D cellular adhesions [178-180]. Thus, 
maintenance of physiological cellular function and specialized tissue 
morphogenesis could be attained on these 3D electrospun matrices [174]. 
 
Figure 28. Cellular morphology and spreading of both HUVEC and IMR90 
fibroblast were compared on a tissue culture polystyrene (TCPS) surface and 
a PCL/Col-Hep electrospun mesh. On TCPS, both cell types were observed 
to be flatter with prominent two dimensional spreading. HUVEC exhibited 
typical flat and cobblestone morphology while fibroblasts were elongated and 
spindle shaped. On the electrospun mesh however, both HUVEC and 
fibroblast showed more 3D contacts and features. Bars represent 40 m in 




 As proper function of EC in a co-culture setting may call for certain 
requirements, variations in cell seeding techniques were performed. Some of 
the variations evaluated were sequential (Seq) seeding of fibroblast followed 
by EC, 3:1 cell ratio of fibroblast to EC (F:EC) and 5:1 ratio of F:EC. The 
culture of EC alone (EC) on the PCL/Col-Hep mesh was included as control. 
These groups had a total of 300,000 cells seeded per mesh on an area of 0.5 
cm2. A higher density (HD) cell seeding of 3,000,000 cells per mesh with 5:1 
F:EC ratio (5:1 HD) was also included in the experimentation. The H & E 
staining and vWF immunofluorescence of the sections and mesh surface after 
14 days of co-culture are shown in Figure 29.  
 Seeding of EC alone as a mono-culture on the PCL/Col-Hep meshes 
did not yield favorable results. The EC formed a monolayer on the surface 
with minimal interior infiltration and no CLS formation. In contrast to the 
results obtained using 2D systems i.e. on normal TCPS, sequential seeding of 
fibroblast followed by EC resulted in an improved infiltration of cells, however 
very few of the infiltrating cells were EC. Surface localization of the EC was 
still prominent with the cells assuming cluster and island-like formations. 
Seeding the cells with a higher fibroblast-to-EC ratio markedly improved the 
results. F:EC ratio of 3:1 showed significant cellular infiltration especially by 
the EC. Uniform distribution of the EC was observed almost throughout the 
thickness of the mesh. Slight elongated EC structures could be seen nearer 
the surface indicating possible CLS formation in the interior. On the surface 
however, no CLS was seen with the EC distributed uniformly as a monolayer. 
F:EC ratio of 5:1 presented the most satisfactory outcome with EC seen 
penetrating the whole thickness of the mesh. The EC located in the interior 
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were observed exclusively as clusters and elongated structures similar to 
those seen in CLSs. Networks of these structures could be seen nearer to the 
surface. On the PCL/Col-Hep surface, CLS formation was also obvious, 
similar to that of a 2D culture. Interestingly, the same F:EC ratio but much 
higher total number of cells i.e. 5:1 HD did not promote such CLS formation 
and obliterated cell infiltration totally. 
 
Figure 29. Co-culture experiments with HUVEC and IMR90 cells were 
performed on the PCL/Col-Hep meshes in order to study their capability of 
supporting EC cell functions. HUVEC cultured alone remained as a monolayer 
of cells with marginal infiltration into the structure. Sequential seeding (seq) of 
IMR90 followed by HUVEC resulted in small islands of EC (*) on the surface. 
Better performance was observed when fibroblast and EC were seeded at a 
ratio of 3:1 and 5:1 (F:EC). Extensive infiltration by HUVEC was seen in both 
groups with the 5:1 group showing CLS formation (arrows) on the surface as 
well as in the interior. High density 5:1 ratio seeding resulted in poorer 
infiltration and a more confluent surface monolayer. Bar represents 20 m in 





 Similar to that of 2D TCPS cultures, the presence of fibroblast i.e. co-
culture was required for the formation of CLS in the 3D PCL/Col-Hep meshes. 
Berthod et al reported that although ECM deposited by fibroblast was 
necessary for CLS formation, close association between the two cell types 
was more critical [181]. Cell motility and angiogenic capability were enhanced 
when EC were cultured with fibroblast in collagen gel and Matrigel systems 
[182]. Fibroblasts deposit collagenous ECM and secrete critical angiogenic 
growth factors such as VEGF and FGF [183-185]. However, in the case of 
PCL/Col-Hep, good CLS formation in the meshes only occurred when the 
total cell number and the cell ratio of EC to fibroblast was optimal.  
 A higher fibroblast to EC ratio in the 3D construct (5:1 vs. 3:1) may 
have provided a more physiological environment, allowing endothelial 
differentiation and CLS formation. Serini et al reported an optimum 
concentration of EC in their 2D in vitro study model whereby too low or too 
high of cell numbers may result in vascular system disorder [186]. It was 
shown previously by Yang et al that fibroblast accumulation preceded 
endothelial capillary infiltration into the wound site [187]. As in vitro cultured 
fibroblast mimic the active state of fibroblast in granulation tissue during the 
wound healing process, their infiltration and accumulation triggered formation 
of endothelial networks in the meshes [188, 189]. As the EC were co-seeded 
simultaneously with the fibroblast, re-arrangement and endothelial assembly 
occurred in the constructs in vitro. Similar organization of endothelial cells into 
elongated and connected cords can be noticed in primitive networks of blood 
vessel formation in vivo [190, 191]. These findings indicate, at the very least, 
that formation of primitive endothelial networks could be achieved in the 
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PCL/Col-Hep meshes. Presently, the complex process of blood vessel 
maturation, pericyte recruitment, and integration to a vascular system cannot 
be mimicked in vitro and thus need to be validated using in vivo 
experimentations in the future. The next logical step for the development of 
the electrospun PCL/Col-Hep as a periosteal replacement scaffold is its 
exploitation as a growth factor releasing vehicle to augment tissue repair.  
 
Electrospun PCL/Col-Hep as a cytokine reservoir 
 
As it is unlikely that large and complex tissue defects can be repaired solely 
by scaffolds or cell transplantation, functional tissue substitutes are 
envisioned to incorporate cells and/or relevant growth factors in an ECM 
mimicking scaffold environment. A controlled-release scaffold system will 
enable more functionality and better control over the cellular 
microenvironment [168]. In the field of therapeutic angiogenesis, VEGF has 
been widely reported as one of the most potent pro-angiogenic factors. 
Nonetheless, bolus injections of VEGF into an injury site pose risks of hyper-
permeabilization of vessels, tumor growth stimulation, hypotension and hyper-
vascularity [192]. Furthermore, rapid diffusion out of the implant site and a 
very short half-life (in a matter of hours) demand multiple applications which 
increase complication risks and cost. Thus a scaffolding material which allows 
infiltration of neo-vessels and incorporation of angiogenic factors will be 
greatly advantageous in functional tissue reconstruction. 
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 The HA-based hydrogel, HeprasilTM, used for electrospraying 
simultaneously with PCL/Col electrospinning has been reported as a vehicle 
for the controlled release of drugs and proteins. Cai et al a reported favorable 
release profile of bFGF from the HA hydrogel when heparin moieties were 
introduced covalently into the gel structure [141]. In vitro, the hydrogel 
supported the attachment and proliferation of murine fibroblast without any 
toxicity [193]. Furthermore, in vivo implantation of bFGF-loaded, heparin 
cross-linked HeprasilTM in a mouse model revealed significant neo-
vascularization into the hydrogel [141]. Incorporation of HeprasilTM into tissue 
scaffolding material however has not yet been reported. Its incorporation into 
electrospun PCL/Col meshes has already been shown to allow penetration of 
cells into the scaffolds and the formation of endothelial CLSs. To further 
develop the potential of the scaffold, its ability to function as a growth factor 
reservoir was also investigated. 
 An initial protein release study from the PCL/Col-Hep meshes was 
performed by loading bovine serum albumin (BSA) proteins with varying 
concentrations into the HeprasilTM electrospraying gel. Three concentrations 
of BSA were tested: 0.375, 0.75 and 1.50 g/cm2 loading over a period of 28 
days. Their release profiles are shown in Figure 30. With all three loading 
concentrations, a burst release of proteins was observed during the initial 
days of study. Burst effects however, were more pronounced with higher 
loading scaffolds. Half of the loaded protein amount was released after 48, 24 
and just 6 hours when the PCL/Col-Hep meshes were loaded with 0.375, 0.75 
and 1.50 g/cm2, respectively. Loading higher amounts of proteins into the 
hydrogel caused a greater concentration gradient between the scaffolds and 
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the environment, increasing the release flux. Following this burst, a slower 
and steadier BSA release ensued up to four weeks. Almost all of the loaded 
BSA was released by the end of the study period. As BSA is negatively 
charged at neutral pH, direct binding to cross-linked heparin was unlikely. 
BSA may have been physically trapped in the hydrogel and was released 
through diffusion and HeprasilTM degradation. 
 
 
Figure 30. Preliminary protein release experiments were performed with BSA 
as model protein. Three different variations of protein loading amount were 
assayed. A burst release of protein was observed in all loading with a more 
pronounced effect with the highest BSA load. Slow release then ensued over 
the course of 28 days where almost all proteins were released. 
 
 As a dose-dependent effect of protein release was seen with BSA, it 
was worth investigating the profiles of actual GFs relevant to the applications 
of the PCL/Col-Hep meshes. Two different loadings of the PCL/Col-Hep were 
performed, one group with a combination of VEGF and PDGF-BB and the 
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other with BMP-2. The loading amounts for all three GFs were kept at 200 
ng/cm2. Their release profiles are shown in Figure 31 A and B, respectively. 
All three GFs displayed distinct release profiles over the course of 35 days. 
An initial burst release of VEGF and PDGF-BB was seen in the early days of 
the study. BMP-2 however demonstrated a lag in the release of the protein. 
Burst release of BMP-2 was seen only after 24 hours of incubation. About 
35% of VEGF was released after three days burst period while 25% was 
released for both PDGF-BB and BMP-2 after the same amount of time. A slow 
and steady protein release followed until completion of the study. In the case 
of PDGF-BB however, protein release ceased after three weeks of incubation 
with only 30% of total loaded amount released. At the final time-point (five 
weeks), about 50% and 38% of loaded VEGF and BMP-2 were released, 
respectively. High efficiency of protein capture as shown by the AlexaFluorTM-
BSA incorporation and release highly suggest similar degree of growth factor 
incorporation. Therefore, the remainder of the growth factors are believed to 
be still trapped in the meshes after 35 days of release and not lost during 
fabrication process.  
 As angiogenesis is a complex process, different factors exert critical 
functions at different stages of vascular development [194]. The combination 
of VEGF and PDGF-BB were employed as the two cytokines have synergistic 
effects during the process of angiogenesis [195]. Although VEGF is a potent 
initiator of neo-vascularization, its presence alone is not sufficient in 
establishing a mature vascular network [196]. Newly sprouted blood vessels 
triggered by the action of VEGF need to be stabilized by the recruitment of 
pericytes. PDGF-BB has been well known to trigger this process leading to 
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the maturation of vessels and the prevention of vessel regression [191, 197]. 
A more mature and stable vasculature in vivo was obtained when VEGF and 
PDGF-BB were administered together in a foam carrier compared to 
individual dosing of either GFs [198]. 
 Although both GFs were loaded into the same mesh, VEGF showed 
continuous release up to five weeks while PDGF-BB release was stunted after 
three weeks. This difference could be attributed to preferential affinity of the 
GFs towards the HA and in particular, the cross-linked heparin moieties. Both 
the VEGF and PDGF families are known to interact with heparin/heparan 
sulfate molecules albeit to differing extents [199-201]. A slower release of 
PDGF-BB compared to VEGF could also be attributed to preferential binding 
of PDGFs towards collagen type I, both native and single chain forms [202, 
203]. The VEGF profile was somewhat similar to a recent work published 
using the HA hydrogel alone by Peattie et al, while their PDGF-AA release 
was much less [204]. PDGF-BB may have been more loosely bound by the 
heparin compared to PDGF-AA, resulting in a greater release of the protein. 
Another contributing factor to the discrepancy in released amount was the 
gelatin mixed into the electrospraying solution. Normal gelatin was used to 
formulate the HeprasilTM electrospraying mix instead of thiol-modified gelatin 
which would have been covalently incorporated into the hydrogel. This 
modification may have caused an earlier degradation of the hydrogel structure 
allowing the escape of GFs into the bulk solution. 
 The release profile of BMP-2 protein was also studied as incorporation 
of this particular cytokine will be useful when bone repair is involved. Unlike 
VEGF and PDGF-BB, BMP-2 showed a 24 hour lag before burst release 
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occurred. A similar lag was also observed when bFGF was loaded into the 
HeprasilTM hydrogels [205]. The reason for this lag remains unclear. BMP-2, a 
potent cytokine in inducing mesenchymal cells into the osteoblastic lineage, is 
 
Figure 31. Release profiles of incorporated growth factors VEGF/PDGF-BB 
(A) and BMP-2 (B) were assayed to study the suitability of PCL/Col-Hep as 
cytokine reservoirs. As observed with BSA, all three growth factors showed 
burst release over the first few days. VEGF and PDGF-BB showed immediate 
burst release while BMP-2 had a lag period prior to burst. VEGF and BMP-2 





also known to possess a heparin binding domain [206]. Association of BMP-2 
with heparin modulates the osteogenic inductive effects of the GF[207]. It has 
been reported elsewhere that BMP-2 bound to heparin conjugated PLGA 
scaffolds showed a much slower release compared to direct adsorption, and 
promoted in vivo bone healing in a rat model [208]. A study by Kim et al 
involving Hyaff-11, a derivatized HA scaffold, revealed a slower and better 
controlled release of BMP-2 compared to collagen gels, with retained 
bioactivity in vitro [209]. Furthermore, the loading of BMP-2 as a potent 
osteogenic inducer into HA-based nano-particles was able to significantly 
improve in vivo bone regeneration [210]. 
 An important point to note is that the release kinetics experiments were 
performed in vitro in the absence of cells. The objective of the study was a 
proof of concept for the meshes to retain and release cytokines by passive 
means i.e. diffusion and degradation. It is certain that the GFs release profile 
in vivo will be altered by the actions of invading cells, resident hyaluronidase 
and unique diffusion gradients.  
  Another universal issue when the electrospinning technique is involved 
in the fabrication of GF loaded scaffolds is the stability and bioactivity of the 
proteins. The possible exposure of proteins to harmful solvents and high 
electrostatic charges could prove detrimental to the GF’s structural integrity. 
To address this issue, cell based bioactivity assays were performed on all 
three GFs released from PCL/Col-Hep at various time-points post 
electrospinning. Their results are shown in Figure 32. All three GFs showed 
acceptable bioactivity after two days of release into bulk solution. Calculated 
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activities were 84%, 88% and 93% for VEGF, PDGF-BB and BMP-2, 
respectively. Bioactivities of the three GFs decreased after one and three 
weeks in solution, with VEGF showing the highest deterioration. After seven 
days, VEGF, PDGF-BB and BMP-2 registered activities of 5%, 42% and 28%, 
respectively. After 21 days, the values were 1%, 20% and 15% for VEGF, 
PDGF-BB and BMP-2, respectively.  
  
 
Figure 32. Bioactivity tests were performed on the released growth factors to 
determine their viability. After two days of release, good viability was observed 
from VEGF and PDGF-BB (A) and BMP-2 (B). At later time-points however 
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marked decrease in bioactivity of VEGF was seen. Slow and gradual 
decrease of bioactivity was seen with PDGF-BB and BMP-2 in vitro after three 
weeks. 
 
 The relatively high values of bioactivity for all three GFs registered after 
just two days of release indicated minimal damage was imparted to the 
proteins during the fabrication of the scaffolds. The incorporation of the 
proteins into the HA hydrogel could have provided protection from solvent 
exposure from the deposited PCL/Col fibers and the application of high 
voltage electric charge. Furthermore, association with heparin moieties may 
have prevented early denaturation of the GFs. Once in solution however GFs 
deteriorated rapidly. VEGF lost 79% of activity in a matter of five days and 
was practically inactive after three weeks. Although significant deterioration 
was also seen with PDGF-BB and BMP-2, their progressions were not as 
dramatic. In a study involving VEGF, BMP-4 and bFGF by Ziegler et al, similar 
deterioration of the GFs in vitro was observed following release from scaffolds 
[211]. VEGF in particular is quite susceptible to in vitro degradation in 
aqueous media presumably via pH dependent deamidation and oxidation 
processes [212, 213]. 
 From the release study, unique release and retention profiles were 
obtained for all three GFs used. After five weeks of in vitro release, half or 
more of the loaded proteins was still retained in the scaffolds. The remainder 
of the proteins will be available for therapeutic use in vivo when host cells 
invade the scaffolds. Due to the unique manufacturing process of the scaffold, 
bioactivities of the GFs were preserved while electrospun fibrous structure 
was maintained. Encapsulation in hydrogels such as gelatin, collagen, HA or 
even synthetic ones like PEG or PVA, allows delivery and controlled release 
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of GFs [214]. Direct incorporation of GFs into the polymer’s bulk material 
would be detrimental as exposure to organic solvents causes protein 
denaturation [215]. As an example, Hile et al reported massive losses in 
bioactivity of bFGF attributed to factors such as organic solvent exposure and 
other harsh processing conditions during the preparation of PLGA foams 
[216].  
 The incorporation of HeprasilTM hydrogel is by no means the only way 
of achieving a GF depository and delivery into electrospun scaffolds. Other 
methods such as electrospinning co-axial fiber structures and embedding 
micro-particles containing proteins to be delivered have been published with 
promising results [217, 218]. However, as the inclusion of HeprasilTM into the 
electrospun meshes was to allow cellular infiltration into the architecture, the 
ability to load and release proteins will be an added merit to the scaffold’s 
functionality. Loading the meshes with VEGF and PDGF-BB is aimed to 
augment the process of neo-vascularization of the scaffolds in the wound site. 
Justifications however, need to be performed in vitro to ascertain if the 
released cytokines are able to elicit an angiogenic response from the cells. 
 
 
In-vitro angiogenesis assay of PCL/Col-Hep loaded 
with VEGF/PDGF-BB 
 
As it was shown in the previous sections, the electrospun PCL/Col-Hep 
meshes allowed cellular infiltration, release of multiple cytokines from its 
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structure and the formation of endothelial networks in its interior. It remains to 
be seen however whether the released angiogenic factors VEGF and PDGF-
BB will have significant effects towards endothelial cells. To investigate this 
facet, in vitro experiments were setup based on the previously established 3D 
co-culture between HUVEC and IMR90 fibroblast. Four culture groups were 
established based on the presence and loading of VEGF and PDGF-BB in the 
system. As a positive control (+ve control), VEGF and PDGF-BB were added 
directly to the culture media. This is to establish EC network formation on and 
in the meshes as previously shown with the constant presence of the 
angiogenic factors. As the negative control (-ve control), the constructs were 
cultured in basal media lacking VEGF and PDGF-BB. Two experimental 
groups were included; one whereby VEGF and PDGF-BB were loaded via 
HeprasilTM through electrospraying (GF Load) and another whereby the GFs 
were pre-loaded just prior to cell seeding (Pre-load). Final loading of GFs in 
these two groups were the same (200 ng of each GF per cm2 of mesh). 
 Constructs from the four culture groups were maintained in vitro for 14 
days. Morphology of the cell-scaffold constructs were studied via SEM and 
shown in Figure 33 below. Cells attached and proliferated on the meshes 
resulting in a well covered surface. After two weeks of culture, indications of 
cellular infiltration into the electrospun meshes’ interior were observed in all 
culture groups. Qualitative observations did not reveal differences between 
samples with angiogenic GFs loaded into the mesh (GF Load) and pre-
loading prior to seeding (Preload). Both samples had similar cellular 
distribution and surface morphology to that of the positive control. The group 
without exogenous addition of GFs (i.e. –ve control) revealed more cellular 
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coverage on the surface. From the electron micrographs, formation of 
endothelial networks and CLS on the surface was not discernable. Thus, 
surface formation of such networks, if any, is likely to be within cell sheets 
found on the surface rather than on top [219]. 
 
 
Figure 33. Cellular morphology of the co-cultured EC and fibroblast at two 
weeks post-seeding was studied via SEM. Co-cultured cells attached well and 
covered the electrospun meshes’ surface uniformly in all groups as seen from 
the insets. Sub-surface localization of cells was seen in all groups as pointed 
out by the arrows. Formation of a more prominent confluent cell sheet was 
observed in the –ve control. Distinct formation of endothelial capillaries was 
not observed through the electron micrographs. Bars represent 10 m in high 
magnification images; 50 m in insets. 
 
 Endothelial specific visualizations were performed on the constructs via 
immunofluorescence against von Willebrand factor (vWF) protein followed by 
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laser confocal microscopy (Fig. 34). Culturing the constructs for 14 days in the 
presence of exogenous VEGF/PDGF-BB in the bulk media (+ve control) 
resulted in extensive formation of EC networks. Prominent elongated 
structures of endothelials were seen forming conspicuous junctions and 
connections as pointed out by white arrows. When the bulk media was devoid 
of the angiogenic factors, VEGF/PDGF-BB (-ve control), no visible networking 
of EC was observed. EC remained predominantly as clusters and islands on 
the surface of the meshes. EC networks however, was formed extensively 
when VEGF/PDGF-BB were loaded into the PCL/Col-Hep meshes (GF Load). 
Extended EC tubules formed numerous connections and linkages comparable 
to that of the +ve control. When VEGF/PDGF-BB proteins were pre-loaded 
into the meshes prior to seeding, most of the EC failed to associate into CLS 
within two weeks of in vitro culture. Although short EC structures with 
junctions were formed, the extent of networking was much less compared to 
GF Load. 
 Cytokines loaded and released directly from the electrospun meshes 
were able to compensate for the lack of GFs in the bulk media and induce 
endothelial capillary-like networks. It is thought that the released GFs from the 
meshes and immediate association with surrounding fibroblast triggered 
endothelial morphogenesis, a process which involves EC vacuole formation, 
sprouting/branching and capillary networking [220]. Interestingly, contact with 
fibroblast alone did not manage to promote extensive capillary networks in the 
meshes. Donovan et al reported the ability of HUVEC to form capillary 
networks in the presence of fibroblast without exogenous VEGF addition 
[172]. The 3D PCL/Col-Hep mesh may restrict interactions between the two 
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cell types especially in the interior; however this highlighted the advantage of 
loading potent angiogenic factors into tissue replacement scaffoldings. The 
method by which the GFs were loaded markedly influenced the success of 
endothelial network formations. Simply loading the meshes with a bolus of   
 
 
Figure 34. Formation of EC networks on the PCL/Col-Hep meshes’ surface 
was visualized via immunofluorescence staining against EC-specific vWF 
proteins. Direct supplementation to the media (+ve control) and loading of 
angiogenic factors VEGF/PDGF-BB into PCL/Col-Hep (GF Load) resulted in 
prominent EC networks. These networks were characterized by long 
extensions of EC CLS with perceptible junctions (white arrows). The lack of 
the GFs in the media (-ve control) prevented the networks from forming. Pre-
loading the meshes with GFs did not cause formation of significant EC 
networks. Von Willebrand stained red while nuclei stained blue. Bars 




VEGF/PDGF-BB of the same amount did not instigate the equivalent effect. 
GFs loaded in this manner may have been adsorbed un-specifically onto 
PCL/Col fibers instead of interacting directly with the HeprasilTM hydrogel and 
heparin moieties. This may cause unnecessary release and degradation 
limiting their potential therapeutic effects. 
 The endothelial tubules and junctions were formed by cooperation of 
multiple EC (Fig. 35). Junctions were formed by growing EC tubules which 
anastomosed to create a complex network [221]. Morphology and size of 
these structures were similar in the +ve control and GF Load meshes. 
Formation of lumens in the interior of these structures is speculated, judging  
 
 
Figure 35. Magnified images of EC junctions in the networks formed on 
PCL/Col-Hep surfaces. The images showed that these junctions were 
associations of multiple EC. There were indications as well that these 
structures also had lumens evident from the imperfect coverage by the EC 
(white arrows). Von Willebrand stained red while nuclei stained blue. Bars 




from the voids seen in the higher resolution images probably resulting from 
immature and imperfect lining by the EC. Similar structural features, 
branching and lumen-like formations have also been reported when EC were 
cultured on ECM hydrogels such as collagen and MatrigelTM [222]. Formation 
of this endothelial network, often called the primary capillary plexus, is critical 
towards the development of a mature and functional circulatory system [194, 
223]. 
 To investigate cellular infiltration and endothelial network formation in 
the interior of the scaffolds’ architecture, histology (hematoxylin & eosin) and 
immunofluorescence against vWF proteins were performed. H & E staining 
(Fig. 36) confirmed cellular infiltration partly observed from the electron 
micrographs. Regardless of presence or method of GF loading, all culture 
groups showed deep and uniform cell infiltration throughout their architecture. 
In the group lacking exogenous GF addition, cell localization was more 
pronounced on the surface. Signs of elongated and cord-like structures 
(indicated by arrows) formation were evident when the constructs were 
exposed to angiogenic factors. These structures were more prominent in the 
+ve control and GF Load groups. Although cell infiltration was extensive in the 
Preload group, elongated structures were not as significant. However, when 
the constructs were deprived of exogenous GFs, no signs of cellular 
elongation and cord formations were observed. Hence, presence of the 
exogenous angiogenic cytokines may not be necessary for cellular infiltration, 
but crucial for the formation of cord-like structures.   
 Specific endothelial localization in the interior was investigated via vWF 
immunofluorescence of PCL/Col-Hep meshes sections (Fig. 37). EC were 
  
112
seen as cell clusters on the surface reflecting sections of the capillary network 
or EC islands observed from the surface staining. The constant presence of 
 
Figure 36. Infiltration of cells and their distribution was studied via histology 
(hematoxylin & eosin) after two weeks post-seeding in all four groups. All 
culture groups showed marked cellular infiltration with uniform distribution. 
Elongated structures (white arrows) were seen prominently in the +ve control 
and GF loaded meshes and to lesser extent, in the pre-loaded mesh. None 
were seen in the –ve control. Bars represent 50 m in all images. 
 
bulk VEGF/PDGF-BB in the media (+ve control) resulted not only in extensive 
infiltration of EC into the mesh’s structure, but also a 3D capillary network 
throughout the interior architecture. A similar capillary network was also 
observed when GFs were loaded via the HeprasilTM hydrogel into PCL/Col-
Hep (GF Load). The EC networks in these groups indicated possible 
formations of rounded elongated cords with lumens (denoted by arrows in Fig. 
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36). Pre-loading the GFs into the meshes resulted in a reduced extent of EC 
infiltrations. Formation of primitive endothelial tubules was very limited as well 
in this culture group. When the constructs were lacking exogenous GFs, 
virtually no EC penetrated the mesh’s interior implying that penetrating cells 
were fibroblast and not EC. 
 
 
Figure 37. Endothelial localizations throughout the thickness of the meshes 
after two weeks post-seeding were visualized via vWF immunofluorescence in 
all four culture groups. Both +ve control and GF loaded meshes exhibited 
extensive EC infiltration and network formations throughout the meshes’ 
architecture. There were indications of lumen formations in the scaffolds’ 
interior as pointed out by the arrows. Minimum EC infiltration and network was 
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found in the –ve control. Pre-loading of the scaffolds with GFs resulted in 
much less prominent infiltration and EC networks. Von Willebrand stained red 
while nuclei stained blue. Bars represent 50 m in all images.  
 
Figure 38. Quantitative comparisons were performed to investigate 
differences in endothelial network formation and the extent of endothelial cell 
infiltrations in the different culture groups. The average length of endothelial 
tubules in the +ve control and GF Load samples was quantified (A) by 
measuring the lengths of tubules between junctions (sample image is shown 
in B, yellow lines indicate measured lengths). No significant differences were 
observed between the CLS formed in the +ve control and GF Load. Also, 
endothelial penetration in all four culture groups was measured (C) by a 
similar grid method used in chapter five to detect the deepest localization of 
vWF signal in the cross-sections. No significant differences were seen in 
penetration depth of endothelial cells in the +ve control and GF Load. EC did 
not penetrate as deep in the Preload group. Bars were 200 m in B and 50 




 Measurements were made to quantitatively compare the quality of the 
endothelial network formation as well as extent of EC penetration into the 
PCL/Col-Hep meshes in the four study groups (Fig. 38). Measurements of 
average lengths of the endothelial tubules from both +ve control and GF Load 
did not yield significant differences (Fig. 38A). In both culture groups average 
lengths of tubules in between junctions in the network were about 150 m. 
Similarly, EC were able to penetrate to similar depths in the +ve control and 
GF Load scaffolds (Fig. 38C). When the analysis was performed on –ve 
control and Preload scaffolds, significant impairment of EC infiltrations were 
observed. Negligible sub-surface penetration was encountered when the cell-
scaffold constructs were culture in the absence of angiogenic growth factors. 
Preloading PCL/Col-Hep meshes with similar amounts of VEGF/PDGF-BB to 
that of GF Load did increase the penetration of EC, but not to the extent of 
+ve control or GF Load. Taken together, the results imply that loading critical 
growth factors into the meshes may very well provide adequate signals 
towards the cells to substitute the constant dosage of cytokines. 
 Capillary morphogenesis occurs when endothelial cells are presented 
with proper extracellular cues i.e. soluble signaling molecules and proper 
ECM components [224]. It is well known that a collagen type I matrix 
promotes endothelial cell survival and micro-capillary organizations [225]. 
Moreover, hyaluronic acid based biomaterials have been shown to promote 
EC attachment and association into networks [226]. These ECM elements 
combined with morphogenic and chemotactic actions of loaded VEGF/PDGF-
BB prompted EC migration into the mesh and formation of endothelial 
capillary structures. Endothelial structures obtained in PCL/Col-Hep were 
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similar to that of other 3D cell co-culture models showing characteristics of EC 
sprouts, extensions, branching networks and tubules with lumens [227]. 
These structures however are known to be immature and fragile, dependent 
on towards VEGF for their survival and development [228, 229]. Although the 
amount of VEGF released from the cell-free PCL/Col-Hep was quite low as 
assayed by ELISA, cellular invasion into the mesh’s structure may have 
accelerated VEGF liberation. Additional VEGF may have been produced by 
co-cultured fibroblast assisting in the survival, migration and organization of 
endothelial capillaries.  
 The formation and invasion of blood vessels into 3D scaffolds are 
essential in determining the final functionality of the implanted device. 
Entrapment of angiogenic GFs, VEGF and PDGF-BB, via HeprasilTM in 
PCL/Col-Hep meshes through electrospraying instigated not only capillary 
networking on the surface, but also throughout the interior of the scaffolds. 
Moreover, the loaded angiogenic factors were able to induce and maintain the 
endothelial tubule network for at least two weeks of in vitro culture. As PDGF-
BB acts in the later stages of vascular maturation, promotion of primitive 
endothelial plexus in the electrospun scaffolds was thought to be driven 
primarily by the actions of VEGF [197]. One approach to enhance neo-
vascularization of an implanted tissue engineering construct is the loading of 
bioactive factors to attract the invasion of host vasculature[198]. Another 
approach involves ex vivo pre-vascularization of the constructs prior to 
implantation and allowing anastomosis with the host circulatory system [230]. 
The ability to create GF loaded PCL/Col-Hep meshes would be a great 
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advantage towards both approaches as incorporated VEGF/PDGF-BB 
facilitated endothelial infiltration and their 3D capillary network formation. 
 Taken together, these results have shown the versatility of electrospun 
PCL/Col-Hep as tissue engineering scaffolds. This novel composite scaffold 
allowed the attachment of endothelials, fibroblast and the co-culture of two 
cell types. When provided with the optimum conditions, these two cell types 
synergistically re-created the primitive formation of endothelial capillary 
networks in vitro. Loading the meshes via their hydrogel components allowed 
controlled release of angiogenic (VEGF & PDGF-BB) and osteogenic (BMP-2) 
factors in vitro. This proved to be a critical advantage as the loaded GFs were 
able to provide the necessary stimulus to promote capillary networking 
throughout the mesh, even without the presence of exogenous factors. To the 
best of our knowledge, this is the first study successfully reporting micro-
capillary formation within an electrospun scaffold mesh structure. Previous 
attempts with electrospun silk scaffolds reported endothelial tubules formation 
on but within the structure [231]. Similar results were observed when a 
bioreactor was utilized to endothelialize electrospun cellulose acetate meshes 
with an explanted perfused artery [232]. In both cases, lack of an interior 
migration of capillaries was due to rudimentary cellular infiltration issues. 
 As the periosteum is a highly fibrous tissue with a vast vascular 
network running through it, the development of PCL/Col-Hep meshes 
described here offers a promising potential as a possible tissue replacement. 
Proper cellular and tissue infiltration should ensure enhanced integration with 
the host, while neo-vascularization will ensure graft survival and ultimately 
functional tissue repair. As bone is a structurally and functionally complex 
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tissue, its regeneration using tissue engineering strategies cannot rely on 
diffusion as the primary transport mechanism for oxygen and nutrients. When 
utilized as a supporting tissue scaffolding to complement other bone graft 
methods, a properly vascularized PCL/Col-Hep mesh as a periosteal graft will 
enhance survival of mesenchymal cells involved in bone repair.  
Materials and methods 
 
Materials. All reagents and chemicals were purchased from Sigma (St. Louis, 
MO) unless otherwise stated. Cell culture reagents and supplements were all 
obtained from Gibco (Grand Island, NY) unless otherwise stated. Medical 
grade PCL was purchased from Absorbable Polymers International 
(Birmingham, AL). Medical grade type I bovine collagen was purchased from 
Symatese Biomateriaux (Chaponost, France). HeprasilTM was obtained as a 
kind gift from Glycosan Biosystems (Salt Lake City, UT). A high voltage 
generator was purchased from Gamma High Voltage Research (Ormond 
Beach, FL). Syringe pumps for electrospinning were purchased from kd 
Scientific (Holliston, MA). Human umbilical vein endothelial cells (HUVEC) 
were purchased from Lonza (Basel, Switzerland) while IMR90 human lung 
fibroblast cells were purchased from ATCC (Manassas, VA). Specialized 
endothelial media and supplements EBM-2 BulletkitTM were purchased from 
Lonza. Growth factors: recombinant human vascular endothelial growth 
factor-165 (VEGF), recombinant human platelet derived growth factors-BB 
(PDGF-BB) and recombinant human bone morphogenetic protein-2 (BMP-2) 




Fabrication of scaffolds and protein loading. Cell-permeable PCL/Col-Hep 
scaffolds were fabricated using the methods and procedure described in the 
previous chapter. Preliminary protein loading and release study was 
performed by using bovine serum albumin (BSA) as a test protein. Three 
different loading amounts were tested: 12 g, 24 g and 48 g in 500 L of 
HeprasilTM electrospraying hydrogel mix. These values correspond to 0.375 
g, 0.75 g and 1.5 g per cm2 of mesh for a 32 cm2 area of deposition. For 
the loading of growth factors VEGF, PDGF-BB and BMP-2, approximately 6.4 
g of the proteins were loaded into 500 L of HeprasilTM hydrogel mix prior to 
electrospraying. This gave an approximate 200 ng/cm2 proteins loaded for a 
32 cm2 area of PCL/Col-Hep deposition. Angiogenic factors VEGF and PDGF-
BB were loaded into a single mesh (200 ng/cm2 loading each) while BMP-2 
was loaded into another. 
 
In vitro cell culture and 2D co-culture model. HUVEC were grown in 
specialized endothelial media EBM-2 in a humidified incubator maintained at 
37 oC with 5% CO2 atmosphere. Culture media was changed twice weekly. 
Sub-culturing of cells was performed once cells reached 60-70% confluency 
using the 0.25% trypsin enzymatic digestion method. Passage 4-5 cells were 
used for 2D and 3D co-culture studies. IMR90 fibroblast were cultured in 
Dulbeccos’ Modified Eagle Media (DMEM) supplemented with 10% fetal calf 
serum and 1% antibiotics. Cells were kept in a humidified incubator 
maintained at 37 oC with 5% CO2 atmosphere. Culture media was changed 
twice weekly. Sub-culturing of cells was performed once cells reached 70-
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80% confluency using the 0.25% trypsin enzymatic digestion method. 
Passage 6-7 cells were used for 2D and 3D co-culture studies.  
 The 2D co-culture model was established as a proof of concept that the 
two cell types could co-exist and form capillary-like structures (CLS) indicating 
a more physiological phenotype of the EC in vitro. A fibroblast monolayer was 
established by seeding 50,000 cells per cm2 onto multi-well TCPS plates and 
culturing for 5 days. Once a monolayer was established, HUVEC were then 
seeded on top with a density of 50,000 cells per cm2. The co-culture was 
further maintained for 7 days in EBM-2. Characterization was performed via 
immunofluorescence staining of the cell layer against von Willebrand Factor 
(vWF) protein, specific marker for EC. After 7 days, the cell layer was fixed 
with ice cold methanol for 10 minutes followed by air drying. The samples 
were then blocked with 10% goat serum for 30 minutes followed by incubation 
with primary polyclonal rabbit antibody against hvWF (DAKO, Glostrup, 
Denmark) for 90 minutes at room temperature. Samples were then washed 
with phosphate-buffered saline with 0.05% Tween-20 (PBS-T) and incubated 
with an AlexaFluor 488-labeled secondary goat antibody against rabbit 
immunoglobulins (Invitrogen, Carlsbad, CA) for 30 minutes at room 
temperature. Following further washings with PBS-T, samples were then 
viewed under an Olympus FV500 laser scanning confocal microscope 
(Olympus, Tokyo, Japan). A mono-culture of HUVEC and fibroblast were 
included in the assay to confirm specificity of vWF antibody towards EC. 
 
Cell attachment and morphology studies. For the study of HUVEC and 
fibroblast attachment and morphology on the PCL/Col-Hep meshes, a low 
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density of each cell type was seeded. PCL/Col-Hep meshes were cut using 
an 8 mm biopsy punch into discs of 0.5 cm2 area. The meshes were then 
sterilized via ethanol immersion and drying followed by UV irradiation for 10 
minutes. Overnight conditioning was performed with the proper media. Onto 
these discs, 3000 cells per cm2 of HUVEC and fibroblast were seeded. Both 
cell types were also seeded at similar densities onto TCPS for a 2D 
comparison. The samples were then maintained in culture for 48 hours in the 
appropriate media for each cell type. After two days of culture, the cells were 
fixed in 3.7% formaldehyde in cytoskeletal buffer (CBS; 10 mM MES buffer 
with 138 mM KCl, 3 mM MgCl2, 2 mM EGTA and 0.3 M sucrose) for actin 
staining and in 2.5% glutaraldehyde for SEM. 
 Actin staining was performed by permeabilizing the cells using 0.1% 
Triton-X 100 in CBS for 5 minutes at room temperature. Cells were then 
washed with CBS, blocked with 1% BSA for 30 minutes and incubated with 
Phalloidin (Invitrogen, Carlsbad, CA) for 45 minutes at room temperature in 
the dark. Samples were then rinsed with CBS prior to incubation with DAPI as 
a counter-stain (0.5 g/mL) for 5 minutes at room temperature. Visualization 
was done through an Olympus FV500 laser scanning confocal microscope. 
For SEM, fixed samples were serially dehydrated with an ethanol gradient 
followed by overnight drying in a dry cabinet. Prior to visualization, samples 
were gold sputter coated using a plasma coater. Imaging was performed 
using a JEOL 5600 electron microscope (JEOL Ltd., Tokyo, Japan). 
 
3D co-culture of HUVEC/fibroblast on PCL/Col-Hep meshes. PCL/Col-Hep 
meshes were cut into discs of 8 mm diameters (0.5 cm2 area) and sterilized 
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via ethanol immersion followed by UV irradiation. The discs were then 
conditioned overnight using EBM-2 media. Several cell seeding combinations 
were employed for the optimization of co-culture systems on the scaffold 
meshes. Sequential seeding involved seeding of 50,000 fibroblast per cm2 
followed by 50,000 EC per cm2 five days later (Seq). Co-seeding EC and 
fibroblast with F:EC ratio of 3:1 and 5:1 involved the inoculation of meshes 
with 225,000 fibroblast:75,000 EC and 250,000 fibroblast:50,000 EC per disc, 
respectively. High-density seeding of 5:1 F:EC ratio was also performed by 
seeding 2,500,000 fibroblast:500,000 EC per disc. For comparison purposes, 
a mono-culture of EC alone was included with 300,000 EC seeded per disc 
seeded. All five groups were maintained exclusively in EBM-2 with full 
supplements for 14 days. 
 After 14 days of culture, cell-scaffold constructs were fixed for histology 
and immunofluorescence. To observe endothelial network formation on the 
scaffolds’ surfaces, whole constructs were fixed in ice-cold methanol followed 
by air drying. The samples were then blocked with 10% goat serum for 30 
minutes at room temperature. Constructs were then incubated in a rabbit 
primary antibody against human vWF for 90 minutes at room temperature. 
Following that, samples were washed with PBS-T and incubated with an 
AlexaFluor 594-labeled goat secondary antibody against rabbit 
immunoglobulins for 30 minutes at room temperature in the dark. After further 
washings, the constructs were viewed under laser scanning confocal 
microscopy (Olympus FV500, Tokyo, Japan). Cellular infiltration and 
endothelial localization in the scaffolds’ architecture were studied by cutting 
the constructs into 10 mm sections using a Leica cryo-microtome after prior 
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embedding in cryo-freezing media (Leica, Wetzlar, Germany). The obtained 
sections were affixed onto poly-L-lysine coated slides for further staining. 
General cellular distribution and infiltration was studied by hematoxylin and 
eosin (H & E) staining of the sections. Endothelial specific localization and 
capillary network formation was investigated via the vWF 
immunofluorescence technique as described above followed by confocal 
microscopy. 
 
BSA and growth factor release from PCL/Col-Hep meshes. Preliminary 
release studies were done by using BSA loaded into PCL/Col-Hep meshes. 
The meshes were cut into 1 cm by 1 cm squares and then immersed in 1 mL 
of PBS as a release buffer. The meshes were kept sterile for the duration of 
the release study (28 days) in a humidified incubator kept at 37 oC with 5% 
CO2 atmosphere. Samplings of the supernatant were performed at hourly 
intervals for the first 6 hours, daily intervals for the first 3 days and then 
weekly intervals until completion of the study. During every sampling, 100 L 
of supernatant was collected and frozen in -20 oC for further analysis. Fresh 
100 L PBS was introduced to maintain buffer volume. Quantitation of BSA in 
the supernatant collected was performed using the BCA protein assay kit as 
per manufacturer’s protocol (Pierce, Rockford, IL). 
 For the release of VEGF, PDGF-BB and BMP-2, cut meshes of 1 cm 
by 1 cm were immersed in 1 mL sterile PBS media containing 1% BSA, 1 mM 
EDTA and 10 g/mL heparin as a release buffer. Six samples each from 
VEGF/PDGF-BB and BMP-2 loaded PCL/Col-Hep meshes were utilized for 
the release study. Collection of 100 L supernatant was made after 1 hour, 
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daily up to three days, weekly up to five weeks. Collected supernatants were 
kept at -20 oC for quantitation. Fresh release buffer of 100 L was introduced 
to maintain buffer volume. Quantitation of cytokines in the collected 
supernatant was performed using respective ELISA kits according to the 
manufacturer’s protocols (R & D Systems). Retained bioactivity of the growth 
factors were measured by virtue of cellular proliferations of HUVEC, fibroblast 
and osteoblasts for VEGF, PDGF-BB and BMP-2 respectively. Cells were 
seeded onto 96 multi-well plates with a density of 3000 cells per cm2 and were 
allowed to attach for 24 hours. Six wells were allocated for each growth factor 
from each mesh from every time-point. The released growth factors from the 
supernatant (after 2, 7 and 21 days of release from the scaffolds) were 
introduced to the cells. The cells were then allowed to proliferate for 48 hours 
before their total DNA was measured by PicoGreenTM dsDNA quantitation kit 
as per manufacturer’s instructions (Invitrogen). As a reference, the same 
amount of fresh growth factors was introduced to cells and their proliferative 
effects were taken as 100% activity.  
 
Angiogenic capability of VEGF/PDGF-BB loaded PCL/Col-Hep meshes. In 
order to study the capability of VEGF/PDGF-BB loaded meshes to support 
and induce neo-vascularization into their structure, EC and fibroblast were 
cultured on PCL/Col-Hep meshes. Four co-culture groups were established: 
constructs with EBM-2 culture media containing angiogenic growth factors 
VEGF and PDGF-BB (+ve control), constructs with VEGF/PDGF-BB loaded in 
their HeprasilTM component (200 ng/cm2 each; GF Load), constructs with 
media and meshes lacking any VEGF and PDGF-BB (-ve control) and 
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constructs with VEGF/PDGF-BB loaded into the PCL/Col-Hep meshes prior  
to cell seeding (200 ng/cm2 each; Preload). Supplementation of bFGF was 
taken out from the media in all culture groups due to their potential angiogenic 
properties and possibility of interference with the VEGF and PDGF-BB effects. 
Cell-scaffold constructs were maintained in their appropriate media for 14 
days in a humidified incubator set at 37 oC with 5% CO2 atmosphere. 
 After 14 days of culture, cell-scaffold constructs were fixed for histology 
and immunofluorescence. To observe surface endothelial networks, cellular 
infiltrations and endothelial distribution in the scaffolds’ architecture, 
immunofluorescence against vWF and H & E staining were performed as 
described before on the whole constructs and sections. Quantitative 
comparisons were performed on the average lengths of endothelial tubules 
from the surface vWF images between the +ve control and GF Load groups. 
For the purpose of these measurements, one endothelial tubule was defined 
as a stretch of connection between junctions in the observed capillary 
network. ImageJ software was used to measure line distance by tracing the 
tubules manually. Calibration was performed in the software to correlate pixel 
number with actual distance. Three samples for each group were analyzed 
with two random images used. From each image, ten random endothelial 
tubules were chosen for measurements. For endothelial infiltration depth 
comparisons, a grid system described in the previous chapters was utilized. A 
grid of ten 10 m wide columns was laid out on a cross-sectional image of a 
cell-scaffold construct stained for vWF. Penetration depths of endothelial cells 
in each of the columns were measured. Penetration depth was defined as the 
deepest distance from the mesh’s surface where vWF signal was found. 
  
126
ImageJ was used to measure line distance with proper pixel-to-length 
calibrations. Three samples for each group were analyzed with two random 
images used. From each image, a grid of ten columns was overlaid. 
 
Statistical analysis. Statistical analysis of data was performed by using a two-


























As increasing progress arise in the field of tissue engineering in pursuit of a 
functional tissue replacement, the developments described in this thesis 
contribute towards that goal. The versatile electrospinning system could be 
utilized to create synthetic-natural composite scaffolds of PCL and collagen 
with surface presentation of the proteins. This feature presents an advantage 
in terms of bio-functionality of the resulting scaffold compared to those 
composed of pure PCL. Although addition of collagen into the PCL fibers 
compromised the resulting mesh’s mechanical strength, the ability of PCL/Col 
meshes to augment bone-like tissue formation was much enhanced, 
highlighting the bioactivity of the fibers. As the electrospinning process has 
been reported to be detrimental towards the secondary and ternary structures 
of proteins, the feasibility of gelatin (a more cost-effective alternative) 
substitution for collagen was worth investigating. However, after mechanical 
and biological examinations, it was concluded that the composite of PCL with 
collagen was still a more superior material compared to that of PCL and 
gelatin. Substituting collagen for gelatin yielded mechanically weaker meshes 
and biologically inferior scaffolds in terms of their ability in supporting 
osteogenic differentiation of mesenchymal progenitor cells. Although collagen 
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denaturation through the electrospinning process may have occurred to a 
certain degree, retention of the protein’s bioactivity persisted. 
 Further advancement of the conventional electrospinning system 
allowed the creation of cell-permeable electrospun scaffolds for a bona fide 
three dimensional (3D) cell-scaffold construct, thus addressing a longstanding 
issue with electrospun meshes. To our knowledge, this is one of the first few 
successful attempts to engineer such constructs. Accomplishing this with 
incorporation of the natural hyaluronic acid based hydrogel, HeprasilTM, 
allowed loading of potent angiogenic factors VEGF/PDGF-BB and osteogenic 
factor BMP-2. Furthermore, the time-release profiles of the growth factors 
were observed indicating the potential of the meshes as cytokine delivery 
vehicles. Incorporation of the proteins via the HeprasilTM component of the 
hybrid mesh caused minimal loss of bio-activity. Integrity of the growth factors 
was successfully maintained through the electrospraying of water-based 
hydrogel.  Electrospun PCL/Col-Hep meshes loaded with VEGF/PDGF-BB 
enabled recapitulation of a primitive endothelial plexus throughout its 
structure, indicating its potential as a truly vascularized 3D scaffold. The 
combination of its osteo-conductive properties and vascularization potential 
makes PCL/Col-Hep a suitable candidate as a periosteal replacement 
scaffolding material. Such material may be used to improve the performance 







It has been shown in this thesis that PCL/Col fibers supported morphogenesis 
of new bony tissue in vitro. It has also been shown that PCL/Col-Hep mesh 
allowed 3D infiltration and formation of endothelial network in its structure. An 
in vitro tri-culture system using three different cell types: endothelial cells, 
fibroblasts and mesenchymal progenitor cells may be employed in order to 
investigate cellular interplay. As a periosteal graft, these three cells are 
relevant as they are the main cellular component in the native periosteum 
niche. However, establishment of a tri-culture system of three different cell 
types is a very complex process. Furthermore, approximations performed in 
an in vitro setting may not be able to reflect the actual environment in vivo. 
Thus it may be advisable to perform further experimentations, angiogenesis or 
osteogenesis or both, in an animal model. 
While the co-culture model is a well established angiogenesis study, 
the complexity of vascular system maturation cannot be reproduced in vitro. 
Thus an in vivo angiogenesis model should be performed to truly examine 
therapeutic effects of loaded VEGF/PDGF-BB in initiating a neo-
vascularization cascade into the scaffold. Following that, its potential as a 
periosteal replacement must be evaluated in a bone defect model.  
 As it is unlikely that a critical bone defect will be repaired by a 
periosteal replacement alone, the study should combine PCL/Col-Hep as a 
support for a load-bearing bone graft. One suitable in vivo model would be a 
large segmental femoral defect developed by Prof. Robert Guldberg’s group 
in the Georgia Institute of Technology. A periosteal replacement may be 
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utilized in this model as a wrap-around tube enveloping the defect site treated 
with a complementary bone repair method (tissue grafts or tissue engineered 
constructs). Preliminary findings with conventional electrospun PCL 
performed by Kolambkar et al (manuscript in preparation) with this method 
yielded promising results. It is envisioned that the usage of PCL/Col-Hep 
meshes as a periosteal graft in this model will enhance the overall bone repair 
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